JP2007153863A - Hair improving external preparation - Google Patents

Hair improving external preparation Download PDF

Info

Publication number
JP2007153863A
JP2007153863A JP2005380876A JP2005380876A JP2007153863A JP 2007153863 A JP2007153863 A JP 2007153863A JP 2005380876 A JP2005380876 A JP 2005380876A JP 2005380876 A JP2005380876 A JP 2005380876A JP 2007153863 A JP2007153863 A JP 2007153863A
Authority
JP
Japan
Prior art keywords
skin
hair
external preparation
vitamin
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005380876A
Other languages
Japanese (ja)
Other versions
JP3965521B2 (en
Inventor
Shunzo Kobayashi
春三 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2005380876A priority Critical patent/JP3965521B2/en
Publication of JP2007153863A publication Critical patent/JP2007153863A/en
Application granted granted Critical
Publication of JP3965521B2 publication Critical patent/JP3965521B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a hair and skin improving external preparation effective in improving skin surface, particularly color of cheeks without causing dermatitis or damage on hair, and dyeing hair in envious gold covering up gray hair of women and improvement of atopic dermatitis. <P>SOLUTION: The hair and skin improving external preparation contains coenzyme Q10, L-cysteine, vitamins A, C and E, and a skin extract of domestic rabbit inoculated with a vaccinia virus. In addition, ingredients other than the vitamin C and the inflammatory skin extract of domestic rabbit inoculated with a vaccinia virus are used with additives for preparation of the external preparation. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、1剤1日1回の塗布による皮膚表皮角質層の改善等により、つるつると滑らかな艶のある皮膚にし、顔の血色をよくし、保湿効果があり、日焼け、色黒、しみ、そばかす、老人性色素斑の美白効果、皺とり効果等の美肌効果があり、更に色黒、しみ、そばかす、老人性色素斑、皺の予防効果がある。
又毛髪を傷めず、皮膚炎も起こさないで白髪のみを金色に染毛する効果がある。
更にアトピー性皮膚炎の改善、又は治癒に使用する、毛髪、皮膚改善外用剤に関する。
The present invention improves the skin's epidermal stratum corneum by application once a day, making it smooth and glossy skin, improving the color of the face, moisturizing effect, sunburn, dark black, blotches Skin whitening effect such as freckles, freckles, and senile pigment spots, and skin removing effects such as wrinkle removal, and also has the effect of preventing dark spots, spots, freckles, senile pigment spots and wrinkles.
It also has the effect of dyeing only white hair golden without damaging hair and causing dermatitis.
Further, the present invention relates to an external preparation for improving hair and skin used for improving or healing atopic dermatitis.

表皮は深部から基底層、有棘層、顆粒層、角質層にわけられる。細胞成分の大部分はケラチノサイト(角化細胞)と呼ばれ、最終的に角質層を構成する角質細胞を作り出す細胞である。表皮角質層は核をはじめ種々の細胞内小器官が消失し、ケラチンと呼ばれる繊維性蛋白で細胞内のほとんどが充たされる。また、細胞膜も細胞の内側から裏打ち蛋白が強固な架橋構造によって結合し、強靭な角質肥厚膜となる。このように表皮では、分裂した基底細胞が順次押し上げられ、形態を変化させながら、合成と分解の複雑な過程を経て、物理的、化学的抵抗性のある角質層を絶えず作り続けている。この角質層は、ウイルス、細菌、カビ、ダニの侵入を防ぎ、抗原の侵入をも防ぎアレルギー反応が起こらない様にしている。  The epidermis is divided from the deep into the basal layer, spiny layer, granule layer, and stratum corneum. Most of the cellular components are called keratinocytes (keratinocytes), and are cells that ultimately make up the stratum corneum that make up the stratum corneum. In the stratum corneum, various organelles such as the nucleus disappear, and most of the cells are filled with a fibrous protein called keratin. In addition, the cell membrane also becomes a tough keratinous thickened membrane by binding the backing protein from the inside of the cell with a strong cross-linked structure. In this way, in the epidermis, the divided basal cells are pushed up one after another, changing the morphology, and continuously creating a stratum corneum that is physically and chemically resistant through a complex process of synthesis and degradation. This stratum corneum prevents the entry of viruses, bacteria, molds and mites, prevents the entry of antigens, and prevents allergic reactions.

紫外線Bは表皮にあたり、日焼けになり、あたりすぎると色黒、しみ、そばかす、老人性色素斑に、紫外線Aは真皮にあたりコラーゲンを結び付けているエラスチンがほどけてもとにもどらなくなり、コラーゲンがなくなり、皺になる。皮膚の乾燥、洗いすぎ、老化によって、皮膚表面の角質層の水分がなくなり、肌荒れ、小皺になる。皮膚表面の角質層の状態が悪化すると、ウイルス、細菌、カビ、ダニの感染、又アレルギー反応が起こりやすくなる。  UV B hits the epidermis and becomes tanned, and if it hits too much, it will not return to the dark skin, blotches, freckles, senile pigment spots, UV A will return to the dermis even if the elastin that binds the collagen is unwound, the collagen will disappear, Become a trap. Drying, overwashing and aging of the skin will cause the skin's stratum corneum to lose moisture, resulting in rough skin and wrinkles. When the state of the stratum corneum on the skin surface deteriorates, virus, bacteria, mold, mite infection and allergic reaction are likely to occur.

皮膚の、色黒、しみ、そばかす、老人性色素斑等の色素沈着は、紫外線やその他の刺戟により引き起こされる過剰なメラニン合成の亢進の結果とされており、美容上大きな問題である。色黒、しみ、そばかす、老人性色素班を防ぐには、メラニンの生成を正常化する物質、例えばL−アスコルビン酸、コウジ酸、システイン、アルブチン、グルタチオン等の美白成分を外用剤にして、塗布するのが一般的である。併しながらこれら美白化粧剤は必ずしも有効性が充分あるとはいえない。
一方皮膚の皺とりにはコエンザイムQ10が有効であり、又コエンザイムQ10を従来からの美白成分と併用することにより、美白効果を増すことが知られているが(例えば、特許文献1参照)、皮膚の日焼け、色黒、しみ、そばかす、老人性色素斑の美白効果、皮膚の皺とり作用のみでなく、更に美肌効果のある外用剤が求められている。
Skin pigmentation such as dark skin, spots, freckles, and senile pigment spots is a result of excessive enhancement of melanin synthesis caused by ultraviolet rays and other acupuncture, and is a serious cosmetic problem. In order to prevent dark skin, stains, freckles, and senile pigment spots, whitening ingredients such as L-ascorbic acid, kojic acid, cysteine, arbutin, and glutathione are used as external preparations. It is common to do. At the same time, these whitening cosmetic agents are not necessarily effective enough.
On the other hand, coenzyme Q10 is effective for removing skin, and it is known that coenzyme Q10 is used in combination with a conventional whitening component to increase the whitening effect (see, for example, Patent Document 1). There is a need for external preparations that have not only sunburn, dark black, stains, freckles, whitening effects of senile pigment spots, and skin wiping effects, but also skin beautifying effects.

毛髪は表皮細胞が変化したもので、皮膚の角質層の主成分とおなじくケラチンより構成されている。毛髪の色は人種により、黒色、褐色、金色、赤色とその色調はいろいろある。白髪はメラノサイトでメラニンの生成が停止するために起こる現象で、一種の老化現象と思われる。毛幹の構造は、外側から中心に向かつて、毛小皮、毛皮質、毛髄質の3層よりなり、更に毛小皮は3層よりなる。隣接した毛小皮間ばかりでなく、毛皮質の内部構造にも細胞膜複合体がある。細胞膜複合体は毛小皮と毛小皮間、ならびに毛皮質内細胞間の接着に寄与し、更に毛皮質内の水分や蛋白質が溶出したり、逆に外部からの水分、ならびにパーマ剤やヘアーカラー剤などの薬液が、毛髪内部の毛皮質に浸透し作用するための通り道になっているようである。毛皮質は毛小皮の内側にあり、皮質細胞が毛髪の長さ方向に規則正しく並んだ細胞の集団で、細胞膜複合体にかこまれて、毛髪の色を決定するメラニン色素を含む。また毛髪のしなやかさ、強さなどの性質を左右する重用な部分である。毛髄質は毛髪の中心部にあり、空洞となった蜂の巣状の細胞が軸方向に並んでおり、メラニン色素を含んでいる。  Hair is a change of epidermal cells, and is composed of keratin, which is the main component of the stratum corneum of the skin. There are various colors of black, brown, gold and red depending on race. Gray hair is a phenomenon that occurs because the production of melanin stops in melanocytes, and it seems to be a kind of aging phenomenon. The structure of the hair shaft is composed of three layers of hair cuticle, fur, and medulla from the outer side to the center, and further, the hair cuticle is formed of three layers. There are cell membrane complexes not only between adjacent cuticles, but also in the fur structure. The cell membrane complex contributes to the adhesion between the hair coat and between the cuticles and between the cells in the fur. Furthermore, the moisture and proteins in the fur are eluted, and the moisture from the outside, as well as the permanent and hair. It seems that a chemical solution such as a color agent becomes a way for penetrating and acting on the fur inside the hair. The fur is inside the hair dermis and is a group of cells in which cortical cells are regularly arranged along the length of the hair, and it contains a melanin pigment that is surrounded by a cell membrane complex and determines the color of the hair. It is also an important part that affects the properties of hair such as suppleness and strength. The medulla is located in the center of the hair, and the honeycomb cells in the form of cavities are aligned in the axial direction and contain melanin pigment.

白髪はメラノサイトにおいてメラニンの生成が停止する髪の老化現象と思われる。従来は染毛により着色している。染毛により毛髪は損傷を受ける。染毛処理はパラフエニレンジアミンなどの低分子の色素前駆体を毛髪中で酸化重合し、発色させる方法が主である。この処理は過酸化水素を主剤とする酸化剤を用いた酸化反応である。この酸化反応を毛髪中で効率よく行うために、アルカリ剤を用いてPHが高い領域で処理が行われることから、酸化剤、アルカリ剤による損傷を受ける。これら薬液は毛小皮と毛小皮間の細胞膜復合体を通り、毛皮質内の細胞膜複合体を通じて毛髪内部に影響を及ぼし、細胞膜複合体そのものの溶出、毛髪内部の蛋白質の溶出が起こる。毛皮質には、毛髪の水分を保持する役割があるが、細胞膜複合体や内部の蛋白質の溶出によりその水分保持機能が損なわれる。そのため環境の温度変化の影響を受けやすくなり、パサつき、ヘアースタイルのまとまりや、もちの悪さ、枝毛や切れ毛の発生などの現象が起こる。更に毛髪表面を覆っている毛小皮の最表面はF層と呼ばれる脂質の層がある。F層に含まれる分岐脂肪酸により毛髪表面の滑らかな感触に関与する機能を持っている。この脂肪酸はアルカリ性溶液で処理すると加水分解され、結合している脂肪酸が遊離する、これで毛髪表面に存在していた疎水性の膜、F層がなくなり、毛髪がギシギシした感触になる。  White hair appears to be an aging phenomenon in which melanin production stops in melanocytes. Conventionally, it is colored by hair dyeing. Hair is damaged by hair dyeing. The hair dyeing treatment is mainly performed by oxidative polymerization of a low molecular weight dye precursor such as paraphenylenediamine in the hair to develop a color. This treatment is an oxidation reaction using an oxidizing agent mainly composed of hydrogen peroxide. In order to efficiently perform this oxidation reaction in the hair, the treatment is performed in a region where the pH is high using an alkali agent, and therefore, damage is caused by the oxidant and the alkali agent. These chemical solutions pass through the cell membrane union between the hair skin and the hair skin and affect the inside of the hair through the cell membrane complex in the fur, causing the cell membrane complex itself to elute and the protein inside the hair to elute. The fur has a role of retaining moisture in hair, but its moisture retention function is impaired by elution of cell membrane complexes and internal proteins. For this reason, it is easily affected by changes in the temperature of the environment, and there are phenomena such as dryness, grouping of hairstyles, poor texture, and generation of split ends and cut hairs. Furthermore, the outermost surface of the hair cuticle covering the hair surface has a lipid layer called F layer. The branched fatty acid contained in the F layer has a function related to the smooth feel of the hair surface. When this fatty acid is treated with an alkaline solution, it is hydrolyzed and the bound fatty acid is liberated, so that the hydrophobic film and F layer present on the hair surface disappear, and the hair feels tinged.

染毛の薬剤に過敏な人は、染毛により皮膚炎を発症し、染毛のたびに、その症状は悪化する。染毛剤で皮膚炎を起こさない、又染毛により毛髪に損傷を与えない、更に女性羨望の白髪を金色に染毛する外用剤が求められている。  People who are sensitive to hair dyeing agents develop dermatitis due to hair dyeing, and the symptoms worsen with each hair dyeing. There is a need for an external preparation that does not cause dermatitis with a hair dye, does not damage the hair by hair dyeing, and further dyes the white hair of female envy.

近年、種々のアレルギー症状を訴え、治療を必要とする人が増加している。アレルギーとは、初めて物質に接触した時には特別な症状を起こさなかった生体が、繰り返し同一物に接することにより、この同一物質に対して最初より高い反応性を示し、生体への異種物質の侵入に対する過剰な予防反応を言う。  In recent years, an increasing number of people complain of various allergic symptoms and need treatment. Allergy is the first time that a living body that has not caused any special symptoms when it comes into contact with the substance repeatedly reacts with the same substance. Say excessive preventive reaction.

アレルギー症状を起こす抗原としては、例えば植物花粉、動物の毛と上皮、ダニ、真菌、種々な食品、室内塵、さらに排気ガス成分、合成内装材などから発散される揮発性科学物質など種々なものが確認されている。  Examples of antigens that cause allergic symptoms include plant pollen, animal hair and epithelium, mites, fungi, various foods, indoor dust, exhaust gas components, volatile chemicals emitted from synthetic interior materials, etc. Has been confirmed.

アレルギーには、抗体の関与する即時型アレルギー反応と、抗体は関与せず感作リンパ球が媒介する遅延型アレルギー反応とがある。このうち、即時型アレルギー反応を引き起こす抗原をアレルゲンとよんでいる。通常正常人がこのアレルゲンに対して過敏な免疫応答を引き起こすことはないが、このアレルゲンにたいして即時型過敏症を示す場会があり、アトピーもこれに属する。  Allergies include immediate allergic reactions involving antibodies and delayed allergic reactions mediated by sensitized lymphocytes without involving antibodies. Of these, antigens that cause immediate allergic reactions are called allergens. Normally, normal people do not elicit an immune response that is hypersensitive to this allergen, but there are occasions where immediate hypersensitivity is shown to this allergen, and atopy belongs to this.

アトピー性皮膚炎の治療法は、今日でも十分に確立されていない。特に重いアトピー性皮膚炎では、民間療法に頼ったり、あるいは副作用の強いステロイドホルモン剤を一時凌ぎに使用して対症療法をおこなっている。なかにはステロイドホルモン外用剤を長期使用して、ステロイドホルモンによる皮膚炎に罹り、難治性となる場合もある。又放線菌の代謝産物からタクロリスムが発見され、免疫抑制剤として使用されてきたが、アトピー性皮膚炎、特に顔面の難治性潮紅性病変に著効を認めている(例えば非特許文献1参照)。併し使用初期刺激性が強く、又リンパ腫の発生、発がん性の危険が指摘されており、専門医の指導のもとでの使用が必要である。今副作用がなく、長期間使用可能なアトピー性皮膚炎に有効な外用剤が求められている。
特開2004−107262号 公報 「皮膚外用剤 その適用と使い方 原田敬之」 第131頁〜第132頁
A cure for atopic dermatitis is not well established today. In particular, for severe atopic dermatitis, symptomatic treatment is performed by relying on folk remedies or temporarily using steroid hormone drugs with strong side effects. In some cases, steroid hormone topical preparations may be used for a long time, resulting in steroid hormone dermatitis and becoming refractory. Tacrolimus has been discovered from the metabolites of actinomycetes and has been used as an immunosuppressant, but has been shown to be highly effective in atopic dermatitis, particularly intractable flushing lesions on the face (see Non-Patent Document 1, for example). . In addition, the initial irritation is strong, and the occurrence of lymphoma and the risk of carcinogenicity have been pointed out, and it is necessary to use under the guidance of a specialist. There is a need for an external preparation effective for atopic dermatitis that has no side effects and can be used for a long time.
JP 2004-107262 A “External preparation for skin and its application and usage” Noriyuki Harada, pages 131-132

1剤1日1回の皮膚への塗布により、色黒、しみ、そばかす、老人性色素斑、皺の予防効果、又皮膚の保湿効果があり、皮膚の日焼け、色黒、しみ、そばかす、老人性色素斑の美白効果、皮膚の皺とり作用のみでなく、掻痒を押さえ掻破等による表皮角質層の破壊を少なくし、更に表皮角質層の改善効果等により、つるつると滑らかな艶のある皮膚にする効果があり、又顔の血色をよくする等の美肌効果を持つ外用剤の提供を課題とした。又この外用剤の全身塗布により表皮角質層の健全化で、ウイルス、細菌、カビ、ダニ等の侵入を防ぎ、又アレルギー反応が起こりにくくなるので、寿命の延長が期待され、又紫外線の影響を早く除去する作用があるので、昼間はUVカットクリームを、夜間は本発見者の外用剤を使用すると、紫外線による皮膚への影響は以前より少なくでき、色黒、しみ、そばかす、老人性色素斑、皺の発生も減少し、つるつるの滑らかな艶のある美しい肌を長く維持でき、更に紫外線による皮膚癌の発生減少が期待されます。  By applying to the skin once a day, it has the effect of preventing dark skin, spots, freckles, senile pigment spots, wrinkles, and moisturizing skin, tanning skin, dark skin, spots, freckles, elderly Not only the whitening effect of sexual pigment spots and the skin wiping action, but also the destruction of the epidermal stratum corneum caused by scratching and scratching, etc., and the improvement effect of the epidermal stratum corneum, etc., to smooth and glossy skin An object of the present invention is to provide an external preparation that has the effect of beautifying and has a skin-beautifying effect such as improving the color of the face. In addition, the whole body application of this external preparation makes the epidermal stratum corneum healthy and prevents the invasion of viruses, bacteria, mold, mites, etc., and allergic reactions are less likely to occur. Because it works quickly, the use of UV cut cream during the daytime and the topical preparation of the discoverer during the night can reduce the effects of ultraviolet rays on the skin. The occurrence of wrinkles is also reduced, beautiful skin with smooth and smooth gloss can be maintained for a long time, and the occurrence of skin cancer due to ultraviolet rays is expected to be reduced.

白髪は毛髪の老化現象と思われている。発明者は本発明者の外用剤の白髪への塗布により白髪を金色に染毛するのを発見し、老化して弱った白髪に種々の悪い影響のない、又染毛者が染毛剤による皮膚炎を起こさない、白髪を女性羨望の金髪に染毛する外用剤の提供を課題とした。  Gray hair is thought to be an aging phenomenon of hair. The inventor discovered that the hair of the present inventor was applied to the white hair by applying the external preparation of the inventor to the white hair, and had no various adverse effects on the aging and weakened white hair. An object of the present invention is to provide an external preparation that does not cause dermatitis and dyes white hair into a female envy blonde.

アトピー性皮膚炎は、皮膚に湿潤感なく、乾燥肌になっている場合が多い。この乾燥肌は、治療に使用するステロイドホルモンを含んだ外用剤を長期間使用すると更に悪化する。ステロイドホルモン外用剤の使用初期には、アトピー性皮膚炎の強い掻痒感が治まつたり、湿疹状態の改善があり、治療効果がよいため、アトピー性皮膚炎に長期にわたり使用されがちである。ステロイド外用剤を長期間使用すると、塗布部の皮膚は次第に黒ずみ、角質化して、乾燥した硬い皮膚へと変化する。この様に角質化した皮膚では個人差はあるものの、皮膚組織が破壊され、さらにダニ、カビ、細菌、ウイルスが取り付きやすくなり、益々アトピー性皮膚炎が治りにくく、悪化するときがある。
そこで本発明者は、アトピー性皮膚炎の患者が安心して使用でき、黒ずみ、角質化して乾燥し、硬くなったアトピー性皮膚炎の皮膚を柔らにし、掻痒を押さえ、掻破による表皮角質層の破壊を少なくし、表皮角質層の再生を促し、ウイルス、細菌、カビ、ダニの感染を防ぎ、アレルギー反応を起こりにくくする外用剤の提供を課題とした。
In many cases, atopic dermatitis has dry skin without feeling moist. This dry skin is further aggravated when a topical agent containing a steroid hormone used for treatment is used for a long period of time. In the early stages of use of steroid hormone topical preparations, it is apt to be used for atopic dermatitis for a long time because it has a strong pruritic sensation in atopic dermatitis, an improvement in eczema state, and a good therapeutic effect. When a steroid external preparation is used for a long period of time, the skin of the application part gradually darkens, becomes keratinized, and changes to dry hard skin. Although there are individual differences in keratinized skin in this way, the skin tissue is destroyed, and mites, molds, bacteria, and viruses are more easily attached, and atopic dermatitis is more difficult to cure and sometimes worsens.
Therefore, the present inventor is able to use patients with atopic dermatitis with peace of mind, darkening, keratinizing and drying, softening the skin of atopic dermatitis that has become hard, holding itching, and destroying the epidermal stratum corneum by scratching The purpose of the present invention was to provide an external preparation that promotes the regeneration of the epidermal stratum corneum, prevents the infection of viruses, bacteria, fungi, and ticks, and prevents the occurrence of allergic reactions.

本発明はコエンザイムQ10、システイン、ビタミンA,C、E,ワクシニアウイルス接種家兎炎症皮膚抽出液、抗ヒスタミン剤、抗アレルギー剤等を含むことを特徴とする毛髪、皮膚改善外用剤。  The present invention relates to an external preparation for improving hair and skin, comprising coenzyme Q10, cysteine, vitamins A, C, E, rabbit skin inoculated with vaccinia virus, antihistamine, antiallergic agent and the like.

親水軟膏500重量部に対して、コエンザイムQ10(0.03〜1.2重量部)Lシステイン(0.48〜2.4重量部)、ビタミンA(0.06〜0.36重量部)、ビタミンC(2.0〜8.0重量部)、ビタミンE(0.4〜1.6重量部)、抗アレルギー作用と掻痒に効果のあるワクシニアウイルス接種家兎炎症皮膚抽出液3.6〜14.4単位、3ml〜12ml(0.6〜2.4重量部)、流動パラフイン(4.4〜13.2重量部)を有する外用剤と、保湿効果を増す為にヒアルロン酸ナトリウム(0.01〜0.1重量部)を加えた2種類の外用剤を作成する。又アレルギー性皮膚炎用外用剤にはヒアルロン酸ナトリウムを含まない本発明の外用剤に、抗アレルギー作用と掻痒に効果のあるロラタジン(0.01〜0.12重量部)、抗ヒスタミン剤の抗アレルギー作用と掻痒に効果のあるクレマスチン(0.001〜0.012重量部)を追加することを特徴とする外用剤であり、各薬剤の相互間が化学的に安定する為、又毛髪及び皮膚面での薬剤の安定吸収の為ビタミンC以外のコエンザイムQ10、Lシステイン、ビタミンA、ビタミンE、ワクシニアウイルス接種家兎炎症皮膚抽出液、ロラタジン、クレマスチンは添加物入りの製剤を用いた毛髪及び皮膚改善外用剤。又本発明の外用剤はクリームとして作成したが、軟膏、ローシヨン等の外用剤組成物の形態とすることが可能である。  Coenzyme Q10 (0.03 to 1.2 parts by weight) L cysteine (0.48 to 2.4 parts by weight), vitamin A (0.06 to 0.36 parts by weight) with respect to 500 parts by weight of the hydrophilic ointment, Vitamin C (2.0 to 8.0 parts by weight), Vitamin E (0.4 to 1.6 parts by weight), vaccinia virus-inoculated rabbit inflammation skin extract effective for antiallergic action and pruritus 3.6 to 14.4 units, 3 ml to 12 ml (0.6 to 2.4 parts by weight), external preparation having fluid paraffin (4.4 to 13.2 parts by weight), sodium hyaluronate (0 0.01 to 0.1 parts by weight) are prepared. The external preparation for allergic dermatitis does not contain sodium hyaluronate. The antiallergic action of loratadine (0.01 to 0.12 parts by weight) and antihistamine is effective for antiallergic action and pruritus. It is an external preparation characterized by adding clemastine (0.001 to 0.012 parts by weight) effective for pruritus and is chemically stable between each drug, and also on the hair and skin surface Co-enzyme Q10 other than vitamin C, L-cysteine, vitamin A, vitamin E, vaccinia virus-inoculated rabbit inflammation skin extract, loratadine, clemastine for hair and skin improvement topical preparations with additives . Moreover, although the external preparation of this invention was created as a cream, it can be set as the form of external preparation compositions, such as ointment and a lotion.

本発明者の外用剤は1日1回皮膚への塗布により皮膚の保湿効果、皮膚の日焼け、色黒、しみ、そばかす、老人性色素斑の美白効果、皮膚の皺とり作用のみでなく、更に本発明者の外用剤が含有するワクシニアウイルス接種家兎炎症皮膚抽出液の皮膚の掻痒を抑える効果により掻破が少なくなり、皮膚の表皮角質層の破壊が少なくなる。これは表皮角質層の改善の一因と考えられる。詳細は不明ですが、また本発明者の外用剤が表皮角質層等を改善する効果により、荒れた皮膚をつるつると滑らかな艶のある皮膚にする効果がある。更に皮膚の日焼け、色黒、しみ、そばかす、老人性色素斑などの黒い皮膚面を美白効果により白くし、白くなった皮膚面と、ビタミンEの末梢血管を拡張し血液循環を改善する効果等により、顔の血色をよくする効果のある外用剤である。顔の皮膚の血色が良くなるのは、入浴後に本発明者の外用剤を全身に塗布すると、塗布後5分程で塗布面がほかほかと熱感を感じ始め約30分程熱感が持続する。詳細は不明で、種々の要因があると考えられるが、この熱感の一因としてはビタミンE等の末梢血管を拡張し血液循環をよくする等の効果の結果と考えられ、皮膚面特に顔の血色がよくなる一因と考察する。この様に本発明者の外用剤は皮膚の保湿効果、日焼け、色黒、しみ、そばかす、老人性色素斑が薄くなるか消失する美白効果、皺が浅くなるか消失する効果、更に皮膚をつるつると滑らかな艶のある血色のいい皮膚にする効果のある美肌外用剤である。今までこの様に1日1回1剤の塗布で保湿作用、日焼け、色黒、しみ、そばかす、老人性色素斑の美白効果、皮膚をつるつると滑らかな艶のある血色のいい皮膚にする効果、皺とり作用のある美肌効果、更にしみ、そばかす、老人性色素斑、皺発生の予防効果を期待出来る外用薬はない。詳細は不明ですが、皮膚の表皮角質層、メラノサイト、真皮等に、この本発明者の外用剤が好影響を及ぼすものと考察する。又この本発明者の外用剤の全身に塗布することによる表皮角質層の健全化は、ウイルス、細菌、カビ、ダニ等の侵入を防ぎ、又アレルギー反応を起こりにくくし、さらに過度の紫外線、乾燥による皮膚の老化の防止になり、ひいては寿命の延長が期待されます。又紫外線の影響を早く除去する作用があるので、昼間はUVカットクリームを、夜間は本発明者の外用剤を使用すると、紫外線による皮膚への影響が少なくなり、色黒、しみ、そばかす、老人性色素斑、皺の発生も減少し、つるつるの滑らかな艶のある血色のいい美しい肌を長く維持でき、更に紫外線による皮膚癌の発生減少が期待されます。又紫外線は小児期から皮膚に損傷を与えているので、紫外線による色黒、しみ、そばかす、老人性色素斑、皺等皮膚変化の予防の為、色黒、しみ、そばかす、老人性色素斑、皺等皮膚の変化の発生前早期に、夜間は本発明者の外用剤の使用と昼間はUVカットクリームの使用による紫外線対策が望ましい。
(試験例1)
美肌効果については、男性4名、女性20名について検討した。各人使用方法の差により多少の差異はあるが、就寝前1日1回の塗布により、10日位使用すると、皮膚面がつるつると滑らかになり、約3ヶ月以上塗布すると、つるつると滑らかな艶のある皮膚になり、顔の血色もよくなり、また保湿効果もある。更に日焼け、しみ、そばかす、色黒、老人性色素斑の美白効果、皺が浅くなるか消失する皺とり効果を認め、肌が本発明者の外用剤の使用前に比べ一段と美しくなる美肌効果を認めた。
The inventor's external preparation is applied not only to the skin moisturizing effect, skin tanning, dark skin, blotches, freckles, whitening effect of senile pigment spots, skin removing effect, Vaccinia virus inoculated rabbit inflammatory skin extract contained in the external preparation of the present inventor reduces scratching by the effect of suppressing skin itching, and the skin epidermal stratum corneum is less damaged. This is thought to contribute to the improvement of the epidermal stratum corneum. Although details are unknown, the external preparation of the present inventor has the effect of improving the epidermal stratum corneum and the like, and has an effect of smoothening the rough skin to make it smooth and glossy. In addition, whitening of the skin, such as sunburn, dark skin, spots, freckles, and senile pigment spots, whitens the skin, whitening skin, and the expansion of peripheral blood vessels of vitamin E to improve blood circulation, etc. Therefore, it is an external preparation effective for improving the color of the face. The skin color of the face is improved when the external preparation of the present inventor is applied to the whole body after bathing, and the applied surface starts to feel the heat of others about 5 minutes after the application, and the heat feeling lasts for about 30 minutes. . The details are unknown, and it is thought that there are various factors, but one of the causes of this heat sensation is thought to be the result of effects such as expanding peripheral blood vessels such as vitamin E to improve blood circulation, and the skin surface, especially the face This is considered to be one of the factors that improve the blood color. In this way, the external preparation of the present inventor has a skin moisturizing effect, sunburn, dark black, blotches, freckles, whitening effect that makes senile pigment spots thinner or disappeared, an effect that makes wrinkles shallower or disappears, and swells the skin It is an external preparation for skin that has an effect of making the skin smooth and glossy. So far, once in a day, it can be moisturized, tanned, dark black, blotches, freckles, whitening effect of senile pigment spots, and smooth and glossy and dark skinned skin. There is no topical medicine that can be expected to have a skin-beautifying effect that has a wrinkle-removing effect, as well as spots, freckles, senile pigment spots and wrinkle-preventing effects. Although details are unknown, it is considered that the external preparation of the present inventor has a positive effect on the epidermal stratum corneum, melanocytes, dermis and the like of the skin. Also, the soundness of the epidermal stratum corneum by applying this inventor's external preparation to the whole body prevents the invasion of viruses, bacteria, molds, mites, etc., makes allergic reactions less likely, and excessive ultraviolet rays, dryness This will prevent the skin from aging, and it is expected to extend its lifespan. In addition, since it has the effect of removing the effects of ultraviolet rays quickly, using UV cut cream during the daytime and the inventor's external preparation at night will reduce the effects of ultraviolet rays on the skin. Occurrence of sexual pigment spots and wrinkles is also reduced, it is possible to maintain smooth, smooth, glossy, ruddy, beautiful skin for a long time, and to reduce the occurrence of skin cancer due to ultraviolet rays. In addition, since ultraviolet rays have damaged the skin since childhood, to prevent skin changes such as darkness, blotches, freckles, senile pigment spots, wrinkles, etc., ultraviolet rays, stains, freckles, freckles, senile pigment spots, It is desirable to take measures against ultraviolet rays by using the inventor's external preparation at night and in the daytime by using a UV cut cream at an early stage before the occurrence of skin changes such as wrinkles.
(Test Example 1)
The skin beautifying effect was examined for 4 men and 20 women. Although there are some differences depending on the usage method of each person, by applying once a day before going to bed, the skin surface becomes smooth when used for about 10 days, and when applied for about 3 months or more, it becomes smooth when smooth. It gives glossy skin, improves the color of the face, and has a moisturizing effect. In addition, the skin whitening effect of sunburn, spots, freckles, dark black, senile pigment spots, the wrinkle removal effect that makes the wrinkles shallower or disappears, and the skin beautifying effect that makes the skin more beautiful than before using the external preparation of the present inventor. Admitted.

本発明者は発明者の外用剤が老化して弱った白髪を傷めないで、白髪のみを金髪に染毛するのを発見した。従来の染毛剤は強酸、強アルカリで処理するので、毛皮質内の細胞膜複合体の損傷、溶出、内部蛋白質の溶出がおこり、毛髪の水分保持機能が低下し、環境の温度の変化を受けやすくなり、髪がパサついたり、ヘアースタイルのまとまりや、もちの悪さ、枝毛、切れ毛が起こる。更に毛皮質のF層がなくなり毛髪がギシギシした感触になる。本発明者の外用剤は強酸,強アルカリ剤を使用せず、毛髪に上記のような損傷をあたえず、むしろ艶がよくなり、生来の美しさを取り戻し、染毛時染毛剤による皮膚炎の発症はない。又1剤1日1回の毛髪、皮膚への塗布により、白髪を金髪に染毛するうえ、さらに皮膚には保湿作用、日焼け、しみ、そばかす、老人性色素斑の美白作用、皺とり作用、つるつると滑らかな艶のある皮膚し、血色をよくする美肌効果をもつ外用剤は今までない。又詳細は不明ですが、黄色から橙黄色の色彩のコエンザイムQ10が毛髪の細胞膜複合体を通り毛髪内に入り着色する可能性がある。
(試験例2)
白髪を金髪に染毛する試験は男性3名、女性6名で実施した。1日1回毛髪に塗布、約30日で薄く金髪に染まり始め、約90日から120日程で全員金髪に染毛できた。染毛による毛髪の損傷はなく、むしろ艶が出て生来の美しさを取り戻した。本発明者の外用剤による皮膚炎の発生はない。
The present inventor has found that the external preparation of the inventor dyes only white hair into blond hair without damaging the white hair that has weakened due to aging. Conventional hair dyes are treated with strong acids and strong alkalis, causing damage to the cell membrane complex in the fur, elution, and elution of internal proteins, reducing the moisture retention function of the hair and receiving changes in the temperature of the environment. It becomes easier, and the hair gets dry, the hair style is lumpy, the stickiness, split ends, and the hair ends. Furthermore, the fur layer of F disappears and the hair feels tingling. The external preparation of the present inventor does not use a strong acid or a strong alkali agent, does not give the hair damage as described above, rather becomes glossy, regains its natural beauty, and dermatitis due to a hair dye during hair dyeing. There is no onset of. In addition, by applying it to hair and skin once a day, the hair is dyed into blonde hair, and the skin is further moisturized, tanned, stained, freckled, whitening of senile pigment spots, moisturizing action, There are no external preparations that have a smooth and glossy skin and a beautiful skin that improves the color of the skin. Although details are unknown, there is a possibility that coenzyme Q10 having a yellow to orange-yellow color passes through the cell membrane complex of hair and enters the hair to be colored.
(Test Example 2)
The test for dyeing gray hair into blond hair was carried out by 3 men and 6 women. Once applied to hair once a day, it started to lightly fade into blonde hair in about 30 days, and all of them were able to dye hair in about 90 to 120 days. There was no damage to the hair due to the dyeing, but rather the luster appeared and the natural beauty was restored. There is no occurrence of dermatitis due to the external preparation of the present inventor.

アトピー性皮膚炎は幼小児期から始まり、掻痒感強く潮紅と小丘疹、あるいは漿液性丘疹で始まり、掻破により糜爛、痂皮を認め、乾燥肌になる。ステロイドホルモン外用剤の使用初期は効果がよく、掻痒感、湿疹状態の改善がみられるなどの治療効果がよいため連用されがちである。ステロイド外用薬を長期使用すると、塗布部位の皮膚は次第に黒ずみ、角質化して硬くなる。角質化した皮膚は、個人差はあるものの、掻破等により表皮角質層が破壊され細菌、カビ、ダニ等が取り付きやすくなり、益々アトピー性皮膚炎が悪化する場合がある。更に長期にステロイド外用剤を使用すると、ステロイドホルモンによる皮膚炎を起こし、更に難治性となる。一方アトピー性皮膚炎に有効なタクロリスム含有軟膏は発癌性があり、専門医の指導の下での使用が必要である。そこで、本発明者は、アトピー性皮膚炎の患者が安心して使用できる副作用のない外用剤を提供する。試験例を提示する。
(試験例3)
アトピー性皮膚炎の治癒効果については男性2名女性2名について検討した。
(1)3才 男性 気管支喘息を伴うアトピー性皮膚炎、治療開始時はステロイドホルモン軟膏と上記組成の本発明者の外用剤を併用して症状は改善した。その後3回ほど発疹が散発的に出現したが、ステロイド軟膏を使用せず、本発明者の外用薬を1日2回病巣に塗布することにより10日程で治癒し、3月ヶ後発症はない。
(2)22才 女性 毎年冬に、背部、胸部、上肢にアトピー性皮膚炎を発症する。本年も同様3月に発症、角質化した、湿潤感のない乾燥肌で、掻痒感強く掻破痕を認めた。ステロイドホルモン軟膏は使用しないで、本発明者の外用薬の塗布により発疹は消失し、掻痒もとれ、乾燥肌も正常化した。その後本発明者の外用薬を塗布しつづけることで7ヶ月後再発はない。
(3)28才 女性 アトピー性皮膚炎、長年ステロイドホルモン軟膏を使用し、難治性のステロイドホルモン軟膏による皮膚炎を発症し、肌は黒ずみ、乾燥、角化し、湿潤感なく、掻痒感強く、掻破痕を見る。カンジダ菌が取り付き、カンジダ性皮膚炎も併発していた。本発明者の外用薬と抗真菌軟膏を併用し、約2ヶ月で、皮膚面はつるつるとなり、湿潤感あり、皮膚の黒ずみ、乾燥、角化、掻痒感もとれ改善している。
(4)9才 男性 アトピー性皮膚炎、これまで症状悪化の時に、ステロイドホルモン軟膏を使用している。皮膚面はアトピー性皮膚炎特有の黒ずみ、角質化し湿潤感のない乾燥肌で、強度の掻痒感があり、掻破痕を認める。ステロイドホルモン軟膏の塗布を中止し、本発明者の外用薬を1日1回塗布約30日で、黒ずんだ、角質化した乾燥肌が、湿潤感をとりもどし、皮膚面はつるつるになり、掻痒感も減少し、皮膚面は正常化しつつある。
(1)(2)の軽症例では自覚症状,他覚症状ないまでに改善している。
(3)(4)の症例では長年のステロイドホルモン外用剤の使用により黒ずみ、角質化し、掻破痕のある乾燥肌が湿潤化し、つるつるになり掻破痕もなくなっており、正常化しつつある。
軽症例では、本発明者の外用薬の塗布のみでアトピー性皮膚炎の発症をおさえることができる。長年のステロイドホルモン外用薬使用例では、完治はまだしていないが、皮膚面の黒ずんで、角質化して硬くなった乾燥肌が黒ずみはとれ、湿潤化し、掻痒も減少又はなくなり、掻破痕も消失し、正常皮膚へと改善されつつある。詳細は不明で、種々の要因があると考えられるが、本発明者の外用薬のワクシニアウイルス接種家兎炎症皮膚抽出液とロラタジンの掻痒に対する効果が皮膚の掻破を少なくし、表皮角質層の破壊が少なくなり、更にアレルギー反応を抑えることが表皮角質層の改善の一因と考察する。又本発明者の外用剤は、効果が良いので長期にわたり使用されがちなステロイドホルモン外用剤の使用期間を短縮でき、ステロイドホルモンの副作用を少なくする事ができる。又この本発明者の外用剤はその組成から殆ど副作用はなく安心して長期間使用できる。
Atopic dermatitis begins in childhood and begins with a strong sensation of flushing and small papules or serous papules. The initial use of steroid hormone topical agents is effective and tends to be used continuously because of its therapeutic effects such as pruritus and improvement of eczema. When a topical steroid is used for a long time, the skin at the site of application gradually darkens and becomes keratinized and hardened. Although the keratinized skin varies among individuals, the epidermal stratum corneum is destroyed by scratching and the like, and bacteria, mold, mites, etc. are likely to be attached, and atopic dermatitis may be further aggravated. If a topical steroid is used for a long period of time, dermatitis due to steroid hormone is caused, and it becomes further intractable. On the other hand, the tacrosum-containing ointment effective for atopic dermatitis is carcinogenic and needs to be used under the guidance of a specialist. Then, this inventor provides the external preparation without the side effect which the patient with atopic dermatitis can use safely. A test example is presented.
(Test Example 3)
The healing effect of atopic dermatitis was examined in 2 males and 2 females.
(1) 3-year-old male Atopic dermatitis with bronchial asthma, and at the start of treatment, steroid hormone ointment and the external preparation of the inventor of the above composition were used in combination, and the symptoms improved. After that, the rash appeared sporadically about 3 times, but the steroid ointment was not used, and the inventor's topical medicine was applied to the lesion twice a day. .
(2) 22-year-old female Atopic dermatitis develops in the back, chest, and upper limbs every winter. In the same year, the skin became keratinized in March, dry skin without moist feeling, and itching and scratching marks were recognized. Without using a steroid hormone ointment, the rash disappeared, itching was recovered, and dry skin was also normalized by applying the topical medicine of the present inventor. After that, by continuing to apply the inventor's external medicine, there is no recurrence after 7 months.
(3) 28-year-old female Atopic dermatitis, long-term use of steroid hormone ointment, developed dermatitis due to intractable steroid hormone ointment, dark skin, dryness, keratinization, no moist feeling, itchy feeling, strong scratching Look at the marks. Candida bacteria were attached, and Candida dermatitis also occurred. Using the topical medicine of the present inventor and an antifungal ointment, the skin surface became smooth and moistened, and the skin was darkened, dried, keratinized, and itchy.
(4) 9-year-old male Atopic dermatitis, steroid hormone ointment has been used so far when symptoms worsen. The skin surface is dark skin peculiar to atopic dermatitis, keratinized and dry skin with no moist feeling, strong pruritus, and scratch marks. Discontinue application of steroid hormone ointment and apply the inventor's topical medicine once a day for about 30 days. The dark, keratinized dry skin regains its moist feeling, the skin surface becomes smooth and itchy. The skin surface is becoming normal.
(1) The mild cases of (2) have improved to the extent that there are no subjective symptoms or objective symptoms.
(3) In the case of (4), the use of a topical steroid hormone preparation has been darkening, keratinized, and dry skin with scratch marks has become wet, smooth and free of scratch marks, and is becoming normal.
In mild cases, the onset of atopic dermatitis can be suppressed only by applying the inventor's external preparation. In the long-term use of steroid hormone topical drugs, complete cure has not yet been achieved, but the darkened skin, keratinized and hardened dry skin becomes darkened, moistened, pruritus is reduced or eliminated, and scratches disappear. However, it is being improved to normal skin. The details are unknown and may be due to various factors, but the effect of the inventor's topical medicine on inflammatory skin extract and loratadine inoculated with vaccinia virus reduces skin scratching and destroys the epidermal stratum corneum This is considered to be one of the reasons for the improvement of the epidermal stratum corneum. In addition, since the external preparation of the present inventor is effective, it can shorten the period of use of the external preparation of steroid hormone, which is often used for a long time, and can reduce the side effects of the steroid hormone. The external preparation of the present inventor has almost no side effects due to its composition and can be used for a long period of time with confidence.

本発明において使用されるコエンザイムQ10は補酵素として生物活性を有し、ミトコンドリアの電子伝達系の構成成分で、ATPの生合成賦活成分としてエネルギーを生み出す働きがある。コエンザイムQ10はユビキノン類(2.3−ジメトキシー5−メチルー6ポリプレニルー1、4ベンゾキノン)の側鎖のイソプレン単位が10である人特有のユビキノン類であり、ユビデカレノン又は補酵素UQ10とも呼ばれている。分子量は863.36で、融点が約48度の黄色から橙黄色の結晶性の粉末で、匂い及び味はない。エーテルに溶けやすく、光によって分解し、着色が強くなる。コエンザイムQ10の添加量としては特に制限されることはないが、好ましくは0.001〜4.0重量部、より好ましくは0.03〜1.2重量部である。これ以上の濃度では皮膚への好影響が向上することが期待できず、又これ以下の濃度では毛髪及び皮膚への好影響が期待されない。  Coenzyme Q10 used in the present invention has biological activity as a coenzyme, is a component of the mitochondrial electron transport system, and has a function of generating energy as a component for activating ATP biosynthesis. Coenzyme Q10 is a ubiquinone peculiar to humans whose isoprene unit in the side chain of ubiquinones (2.3-dimethoxy-5-methyl-6polyprenyl-1,4benzoquinone) is 10, and is also called ubidecalenone or coenzyme UQ10. It is a yellow to orange-yellow crystalline powder having a molecular weight of 863.36 and a melting point of about 48 degrees, and has no smell or taste. Easily soluble in ether, decomposes by light and becomes more colored. The amount of coenzyme Q10 added is not particularly limited, but is preferably 0.001 to 4.0 parts by weight, more preferably 0.03 to 1.2 parts by weight. If the concentration is higher than this, it cannot be expected that the positive effect on the skin is improved, and if the concentration is lower than this, the positive effect on the hair and skin is not expected.

本発明において使用されるシステインは、生体内代謝系において、SH供与体としての役割を果たし、SH酵素の賦活剤として作用する。皮膚代謝の正常化、抗アレルギー、解毒作用がある。システインもしくはその誘導体としても特に限定されるものではないが、L−システインの誘導体としては、N−アセチルーL−システイン、L−ホモシステイン、L−システイン酸、L−ホモシステイン酸、L−システインスルフィン酸、S−スルフイノーL−システイン、S−スルホーL−システイン、シスチンなどを挙げる事が出来る。又L−システインおよびその誘導体の塩としては、塩酸塩、硝酸塩、硫酸塩等の鉱酸塩、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩などのアルカリ金属塩、アルカリ土類金属塩を挙げることが出来る。本発明において、L−システイン、その誘導体またはそれらの塩としてはL−システインが好ましい。  Cysteine used in the present invention plays a role as an SH donor in the in vivo metabolic system and acts as an activator of SH enzyme. Has normal skin metabolism, anti-allergy and detoxification. Cysteine or its derivative is not particularly limited, but examples of L-cysteine derivatives include N-acetyl-L-cysteine, L-homocysteine, L-cysteic acid, L-homocysteic acid, L-cysteine sulfin. Examples thereof include acids, S-sulfinol L-cysteine, S-sulfo L-cysteine, and cystine. Examples of salts of L-cysteine and derivatives thereof include mineral salts such as hydrochloride, nitrate and sulfate, alkali metal salts such as sodium salt, potassium salt, calcium salt and magnesium salt, and alkaline earth metal salts. I can do it. In the present invention, L-cysteine is preferred as L-cysteine, a derivative thereof or a salt thereof.

本発明において使用されるビタミンAは網膜の暗順応を高める作用、皮膚、粘膜の異常乾燥、角化を改善し、疾病に対する抵抗力を増す作用がある。ビタミンA類としては特に限定されるものではないが、その具体例として、レチノール、デヒドロレチノール、酢酸レチノール、パルミチン酸レチノールもしくはこれらの誘導体等が挙げられ、レチノールの類縁化合物であるレチノイドとしてはレチナール、レチニールエステル、レチノイン酸等の誘導体が挙げられる。本発明において、レチノール、その誘導体としてはパルミチン酸レチノールが好ましい。  Vitamin A used in the present invention has an action of increasing dark adaptation of the retina, an abnormal dryness and keratinization of the skin and mucous membranes, and an action of increasing resistance to diseases. Vitamin A is not particularly limited, and specific examples thereof include retinol, dehydroretinol, retinol acetate, retinol palmitate, or derivatives thereof. Retinoids that are analogs of retinol include retinal, Derivatives such as retinal ester and retinoic acid are listed. In the present invention, retinol and its derivative are preferably retinol palmitate.

本発明において使用されるアスコルビン酸もしくはその塩は、当初は抗壊血病作用を有すると考えられてきたが、更に生体内における細胞間基質とコラーゲンの形成維持に必要で、アスコルビン酸の投与により、コラーゲンの増加が見られる。又メラニン色素生成に関与し、チロジンからメラニンへの生成過程を抑制する。更に酸化型の濃色メラニンを還元型の淡色メラニンに変える作用があり、色素の異常沈着を防ぐ。更に蛋白質の代謝、内分泌機能にも関与する重用な物質である。ビタミンC類としては特に限定されるものではないが、その具体例として、L−アスコルビン酸およびその誘導体またはそれらの塩としては、塩酸塩、硝酸塩、硫酸塩等の鉱酸塩、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩等のアルカリ金属塩、アルカリ土類金属塩等を挙げることが出来る。L−アスコルビン酸、およびその誘導体またはそれらの塩としては、L−アスコルビン酸、L−アスコルビン酸ナトリウム、L−アスコルビン酸カリウム、L−アスコルビン酸カルシウム、L−アスコルビン酸マグネシウムなどのL−アスコルビン酸塩、L−アスコルビン酸モノステアレート、L−アスコルビン酸モノパルミテート、L−アスコルビン酸モノオレエート等のアスコルビン酸モノアルキルまたはモノアルケニルエステル類;L−アスコルビン酸ジステアレート、L−アスコルビン酸ジパルミテート、L−アスコルビン酸ジオレエート等のL−アスコルビン酸ジアルキルまたはジアルケニルエステル類;L−アスコルビン酸トリステアレート、L−アスコルビン酸トリパルミテート、L−アスコルビン酸トリオレエート等のL−アスコルビン酸トリアルキルまたはトリアルケニルエステル類;L−アスコルビル硫酸、L−アスコルビル硫酸ナトリウム、L−アスコルビル硫酸カリウム、L−アスコルビル硫酸マグネシウム、L−アスコルビル硫酸カルシウム等のL−アスコルビン酸硫酸エステル類;L−アスコルビルリン酸、L−アスコルビルリン酸ナトリウム、L−アスコルビルリン酸カリウム、L−アスコルビルリン酸マグネシウム、L−アスコルビルリン酸カルシウム等のL−アスコルビン酸リン酸エステル類など;L−アスコルビン酸グリコシド等のアスコルビン酸配糖体などを挙げることが出来る。本発明において、L−アスコルビン酸、その誘導体またはそれらの塩としてはL−アスコルビン酸が好ましい。  Ascorbic acid or a salt thereof used in the present invention was originally considered to have an anti-scurvy effect, but is further necessary for maintaining the formation of intercellular matrix and collagen in vivo, and ascorbic acid is administered by administration. Increase in collagen is seen. It is also involved in melanin pigment production and suppresses the production process from tyrosin to melanin. In addition, it has the effect of changing oxidized dark melanin to reduced light melanin, preventing abnormal pigmentation. Furthermore, it is an important substance involved in protein metabolism and endocrine function. Although it does not specifically limit as vitamin Cs, As the specific example, L-ascorbic acid and its derivative (s) or those salts are mineral salts, such as hydrochloride, nitrate, a sulfate, sodium salt, potassium Examples thereof include alkali metal salts such as salts, calcium salts and magnesium salts, and alkaline earth metal salts. Examples of L-ascorbic acid and its derivatives or salts thereof include L-ascorbic acid salts such as L-ascorbic acid, sodium L-ascorbate, potassium L-ascorbate, calcium L-ascorbate, and magnesium L-ascorbate. L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, ascorbic acid monoalkyl or monoalkenyl esters such as L-ascorbic acid monooleate; L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid L-ascorbic acid dialkyl or dialkenyl esters such as dioleate; L-ascorbic acid tristearate, L-ascorbic acid tripalmitate, L-ascorbic acid trioleate, etc. L-ascorbic acid sulfates such as L-ascorbyl sulfate, sodium L-ascorbyl sulfate, potassium L-ascorbyl sulfate, magnesium L-ascorbyl sulfate, calcium L-ascorbyl sulfate; L-ascorbyl sulfate; L-ascorbic acid phosphates such as ascorbyl phosphate, sodium L-ascorbyl phosphate, potassium L-ascorbyl phosphate, magnesium L-ascorbyl phosphate, calcium L-ascorbyl phosphate, etc .; ascorbic acid such as L-ascorbic acid glycoside Examples include glycosides. In the present invention, L-ascorbic acid, its derivative or a salt thereof is preferably L-ascorbic acid.

ビタミンEは妊娠、出産と関係あり、不老長寿の薬と言われ、末梢血管を拡張し血液循環をよくする働きがあり、ビタミンEとコエンザイムQ10は両成分が協力して電子の移動を調整し、体内の酸化反応を抑制するなど、非常に関係の強い成分同士として知られている。ビタミンE類としては、特に限定されるものではないが、その具体例としてはコハク酸トコフエロール、酢酸トコフエロール、ニコチン酸トコフエロールもしくはこれらの誘導体が挙げられる。本発明において、ビタミンE、その誘導体としてはニコチン酸トコフエロールが好ましい。  Vitamin E is related to pregnancy and childbirth, and is said to be a longevity drug. It works to dilate peripheral blood vessels and improve blood circulation. Vitamin E and coenzyme Q10 coordinate the movement of electrons through the cooperation of both components. It is known as a very closely related component, such as suppressing the oxidation reaction in the body. Vitamin E is not particularly limited, and specific examples thereof include tocopherol succinate, tocopherol acetate, tocopherol nicotinate or derivatives thereof. In the present invention, vitamin E and its derivative are preferably tocopherol nicotinate.

ワクシニアウイルス接種家兎炎症皮膚抽出液は皮膚の掻痒、冷感、異常知覚に、腰痛症、神経痛等の痛みに効果があり、抗アレルギー作用もある医薬品である。  Vaccinia virus-inoculated rabbit inflammation skin extract is an effective drug for itching, cooling and abnormal perception of skin, as well as low back pain, neuralgia, and other anti-allergic effects.

抗ヒスタミン剤としてはジフェンヒドラミン、トリペレナミン、フェノチアジン、ジフェニルピラリン、塩酸ジプロヘプタジン、塩酸ホモクロルシクリジン、フマル酸クレマスチン、マレイン酸クロルフェニラミン等、抗アレルギー剤としては塩酸アゼラスチン、塩酸エピナスチン、塩酸オザグレル、塩酸オロバタジン、塩酸セチリジン、塩酸フェキソフエナジン、ロラタジン等を挙げることが出来る。ロラタジンはヒスタミンH1受容体拮抗作用と抗原誘発反応抑制作用があり、皮膚疾患の掻痒に効果があり、抗アレルギー作用もある抗アレルギー剤である。本発明においてはロラタジンが好ましい。  Antihistamines include diphenhydramine, tripelenamine, phenothiazine, diphenylpyraline, diproheptadine hydrochloride, homochlorcyclidine hydrochloride, clemastine fumarate, chlorpheniramine maleate, and antiallergic agents include azelastine hydrochloride, epinastine hydrochloride, ozagrel hydrochloride, olobatadine hydrochloride, hydrochloric acid Examples include cetirizine, fexofenadine hydrochloride, and loratadine. Loratadine is an antiallergic agent that has histamine H1 receptor antagonistic action and antigen-induced reaction inhibitory action, is effective in pruritus of skin diseases, and also has antiallergic action. In the present invention, loratadine is preferred.

以下に実施例を示して本発明を説明するが、本発明は以下の実施例に限定されるものではない。  The present invention will be described below with reference to examples, but the present invention is not limited to the following examples.

本発明の外用剤には、クリーム基材として使用される親水軟膏と流動パラフインが使用されている。さらに、必須成分として、コエンザイムQ10、L−システイン、ビタミンA,C,E,抗アレルギー作用と掻痒に効果のあるワクシニアウイルス接種家兎炎症皮膚抽出液を加えた外用剤を、又アトピー性皮膚炎の外用剤には上記外用剤に抗アレルギー作用と掻痒に効果のあるロラタジン、クレマスチンを追加配合する。更に保湿効果を増すためにはヒアルロン酸ナトリウムを加えた外用剤を作成する。使用した薬剤は、各薬剤の相互間が化学的に安定する為、又毛髪及び皮膚面での薬剤の安定吸収の為、ビタミンC以外のコエンザイムQ10、Lシステイン、ビタミンA、ビタミンE、ワクシニアウイルス接種家兎炎症皮膚抽出液、ロラタジン、クレマスチンは添加物入りの製剤を用いた。  In the external preparation of the present invention, hydrophilic ointment and fluid paraffin used as a cream base are used. Furthermore, as an essential component, a topical preparation containing coenzyme Q10, L-cysteine, vitamins A, C, E, vaccinia virus-inoculated rabbit inflammation skin extract effective for antiallergic action and pruritus, and atopic dermatitis In addition to these external preparations, loratadine and clemastine, which are effective for antiallergic action and pruritus, are added to the above external preparations. In order to further increase the moisturizing effect, an external preparation containing sodium hyaluronate is prepared. The drugs used are chemically stable between each drug, and for stable absorption of drugs on the hair and skin, coenzyme Q10 other than vitamin C, L cysteine, vitamin A, vitamin E, vaccinia virus For the inoculated rabbit inflammation skin extract, loratadine and clemastine, preparations containing additives were used.

(実施例1)
毛髪、皮膚改善外用剤は以下の組成で、常法により外用剤を製造した。
NEソフトカプセル(ニコチン酸トコフエロール200mg) 20錠(軟カプセルは除く)
チョコラA(パルミチン酸レチノール) 30ml
アデリール錠(コエンザイムQ10、ユビデカレノン)10mg 300錠(粉砕後)
ハイチオール散32%(Lシステイン) 15g
アスコルビン酸(日本薬局法) 20g
ナブトピン(ワクシニアウイルス接種家兎炎症皮膚抽出液 7.2単位 6ml
流動パラフイン(日本薬局法) 50ml
親水軟膏 (日本薬局法) 500g
Example 1
The external preparation for hair and skin improvement had the following composition, and the external preparation was produced by a conventional method.
NE soft capsule (tocopherol nicotinate 200 mg) 20 tablets (excluding soft capsules)
Chocola A (retinol palmitate) 30ml
Adeliel Tablets (Coenzyme Q10, Ubidecarenone) 10mg 300 tablets (after grinding)
Hythiol powder 32% (L cysteine) 15g
Ascorbic acid (Japanese Pharmacy Law) 20g
Nabutopine (Vaccinia virus inoculated rabbit inflammation skin extract 7.2 units 6 ml
Flowing paraffin (Japanese Pharmacy Law) 50ml
Hydrophilic ointment (Japanese Pharmacy Law) 500g

(実施例2)
皮膚改善外用剤の保湿効果を増すため、以下の組成で、常法により外用剤を製造した。
NEソフトカプセル(ニコチン酸トコフエロール200mg) 20錠(軟カプセルは取り除く)
チョコラA(パルミチン酸レチノール) 30ml
アデリール錠(コエンザイムQ10、ユビデカレノン)10mg 300錠(粉砕後)
ハイチオール散32%(Lシステイン) 15g
アスコルビン酸(日本薬局法) 20g
ナブトピン(ワクシニアウイルス接種家兎炎症皮膚抽出液)7.2単位 6ml
流動パラフイン(日本薬局法) 50ml
親水軟膏 (日本薬局法) 500g
ヒアルトーワ(ヒアルロン酸ナトリウム) 10ml、100mg
(Example 2)
In order to increase the moisturizing effect of the external preparation for skin improvement, an external preparation was produced by a conventional method with the following composition.
NE soft capsule (tocopherol nicotinate 200mg) 20 tablets (remove soft capsule)
Chocola A (retinol palmitate) 30ml
Adeliel Tablets (Coenzyme Q10, Ubidecarenone) 10mg 300 tablets (after grinding)
Hythiol powder 32% (L cysteine) 15g
Ascorbic acid (Japanese Pharmacy Law) 20g
Nabutopin (Vaccinia virus inoculated rabbit inflammation skin extract) 7.2 units 6ml
Flowing paraffin (Japanese Pharmacy Law) 50ml
Hydrophilic ointment (Japanese Pharmacy Law) 500g
Hyaltowa (sodium hyaluronate) 10ml, 100mg

(実施例3)
アトピー性皮膚炎の外用剤のため、以下の組成で、常法により外用剤を製造した。
NEソフトカプセル(ニコチン酸トコフエロール200mg) 20錠(軟カプセルは取り除く)
チョコラA(パルミチン酸レチノール) 30ml
アデリール錠(コエンザイムQ10、ユビデカレノン)10mg 300錠(粉砕後)
ハイチオール散32%(Lシステイン) 15g
アスコルビン酸(日本薬局法) 20g
ナブトピン(ワクシニアウイルス接種家兎炎症皮膚抽出液)7.2単位 6ml
流動パラフイン(日本薬局法) 50ml
親水軟膏 (日本薬局法) 500g
クラリチン錠10mg(ロラタジン) 20錠(粉砕後)
(Example 3)
For external preparations for atopic dermatitis, external preparations were produced by the usual method with the following composition.
NE soft capsule (tocopherol nicotinate 200mg) 20 tablets (remove soft capsule)
Chocola A (retinol palmitate) 30ml
Adeliel Tablets (Coenzyme Q10, Ubidecarenone) 10mg 300 tablets (after grinding)
Hythiol powder 32% (L cysteine) 15g
Ascorbic acid (Japanese Pharmacy Law) 20g
Nabutopin (Vaccinia virus inoculated rabbit inflammation skin extract) 7.2 units 6ml
Flowing paraffin (Japanese Pharmacy Law) 50ml
Hydrophilic ointment (Japanese Pharmacy Law) 500g
Claritin tablets 10mg (loratadine) 20 tablets (after grinding)

(実施例4)
アトピー性皮膚炎の外用剤のため、以下の組成で、常法により外用剤を製造した。
NEソフトカプセル(ニコチン酸トコフエロール200mg) 20錠(軟カプセルは取り除く)
チョコラA(パルミチン酸レチノール) 30ml
アデリール錠(コエンザイムQ10、ユビデカレノン)10mg 300錠(粉砕後)
ハイチオール散32%(Lシステイン) 15g
アスコルビン酸(日本薬局法) 20g
ナブトピン(ワクシニアウイルス接種家兎炎症皮膚抽出液)7.2単位 6ml
流動パラフイン(日本薬局法) 50ml
親水軟膏 (日本薬局法) 500g
ラクレチン ドライシロップ(フマル酸クレマスチン1.34mg) 20g
Example 4
For external preparations for atopic dermatitis, external preparations were produced by the usual method with the following composition.
NE soft capsule (tocopherol nicotinate 200mg) 20 tablets (remove soft capsule)
Chocola A (retinol palmitate) 30ml
Adeliel Tablets (Coenzyme Q10, Ubidecarenone) 10mg 300 tablets (after grinding)
Hythiol powder 32% (L cysteine) 15g
Ascorbic acid (Japanese Pharmacy Law) 20g
Nabutopin (Vaccinia virus inoculated rabbit inflammation skin extract) 7.2 units 6ml
Flowing paraffin (Japanese Pharmacy Law) 50ml
Hydrophilic ointment (Japanese Pharmacy Law) 500g
Lacretin dry syrup (clemastine fumarate 1.34mg) 20g

【0001】
本発明は皮膚の血色特に顔面の頬部の血色をよくする効果がある。
又毛髪を傷めず、皮膚炎も起こさないで白髪のみを金色に染色する効果がある。
更にアトピー性皮膚炎の改善作用のある毛髪、皮膚改善外用剤に関する。
【発明の開示】
【発明が解決しようとする課題】
[0001]
The present invention is effective in improving the color of the skin, particularly the color of the cheeks of the face.
It also has the effect of dyeing only white hair in gold without damaging the hair and causing dermatitis.
Furthermore, it is related with the hair and skin improvement external preparation which have the effect of improving atopic dermatitis.
DISCLOSURE OF THE INVENTION
[Problems to be solved by the invention]

【0012】
1剤1日1回の皮膚への塗布により、色黒、しみ、そばかす、老人性色素斑、皺の予防効果、又皮膚の保湿効果があり、皮膚の日焼け、色黒、しみ、そばかす、老人性色素斑の美白効果、皮膚の皺とり作用のみでなく、掻痒を押さえ掻破等による表皮角質層の破壊を少なくし、更に表皮角質層の改善効果等により、つるつると滑らかな艶のある皮膚にする従来知られていた効果があり、更に新しく今まで知られていなかった効果、顔の特に頬の血色をよくする効果を持つ外用剤の提供を課題とした。又この外用剤の全身塗布により表皮角質層の健全化で、ウイルス、細菌、カビ、ダニ等の侵入を防ぎ、又アレルギー反応が起こりにくくなるので、寿命の延長が期待され、又紫外線の影響を早く除去する作用があるので、昼間はUVカットクリームを、夜間は本発見者の外用剤を使用すると、紫外線による皮膚への影響は以前より少なくでき、色黒、しみ、そばかす、老人性色素斑、皺の発生も減少し、つるつるの滑らかな艶のある美しい肌を長く維持でき、更に紫外線による皮膚癌の発生減少が期待されます。
【課題を解決するための手段】
[0012]
By applying to the skin once a day, it has the effect of preventing dark skin, spots, freckles, senile pigment spots, wrinkles, and moisturizing skin, tanning skin, dark skin, spots, freckles, elderly Not only the whitening effect of sexual pigment spots and the skin wiping action, but also the destruction of the epidermal stratum corneum caused by scratching and scratching, etc., and the improvement effect of the epidermal stratum corneum, etc., to smooth and glossy skin Therefore, it was an object to provide an external preparation having a conventionally known effect, a new and unknown effect, and an effect of improving the color of the face, especially the cheek. In addition, the whole body application of this external preparation makes the epidermal stratum corneum healthy and prevents the invasion of viruses, bacteria, mold, mites, etc., and allergic reactions are less likely to occur. Because it works quickly, the use of UV cut cream during the daytime and the topical preparation of the discoverer during the night can reduce the effects of ultraviolet rays on the skin. The occurrence of wrinkles is also reduced, beautiful skin with smooth and smooth gloss can be maintained for a long time, and the occurrence of skin cancer due to ultraviolet rays is expected to be reduced.
[Means for Solving the Problems]

本発明はコエンザイムQ10、システイン、ビタミンA,C、E,ワクシニアウイルス接種家兎炎症皮膚抽出液を含有する毛髪、皮膚改善外用剤。The present invention is an external preparation for improving hair and skin containing coenzyme Q10, cysteine, vitamins A, C, E, vaccinia virus-inoculated rabbit inflammation skin extract.

【0016】
親水軟膏500重量部に対して、コエンザイムQ10(0.03〜1.2重量部)Lシステイン(0.48〜2.4重量部)、ビタミンA(0.06〜0.36重量部)、ビタミンC(2.0〜8.0重量部)、ビタミンE(0.4〜1.6重量部)、抗アレルギー作用と掻痒に効果のあるワクシニアウイルス接種家兎炎症皮膚抽出液3.6〜14.4単位、3ml〜12ml(0.6〜2.4重量部)、流動パラフイン(4.4〜13.2重量部)を含有する外用剤を作成する。各薬剤の相互間が化学的に安定する為、又毛髪及び皮膚面での薬剤の安定吸収の為ビタミンC、ワクシニアウイルス接種家兎炎症皮膚抽出液以外のコエンザイムQ10、Lシステイン、ビタミンA、ビタミンEは添加物入りの製剤を用いた毛髪及び皮膚改善外用剤。又本発明の外用剤はクリームとして作成したが、軟膏、ローション等の外用剤組成物の形態とすることが可能である。
【発明の効果】
[0016]
Coenzyme Q10 (0.03 to 1.2 parts by weight) L cysteine (0.48 to 2.4 parts by weight), vitamin A (0.06 to 0.36 parts by weight) with respect to 500 parts by weight of the hydrophilic ointment, Vitamin C (2.0 to 8.0 parts by weight), Vitamin E (0.4 to 1.6 parts by weight), vaccinia virus-inoculated rabbit inflammation skin extract effective for antiallergic action and pruritus 3.6 to An external preparation containing 14.4 units, 3 ml to 12 ml (0.6 to 2.4 parts by weight) and fluid paraffin (4.4 to 13.2 parts by weight) is prepared. Vitamin C, coenzyme Q10 other than rabbit skin inoculated vaccinia virus, L-cysteine, vitamin A, vitamins for chemical stability between each drug and for stable absorption of drugs on the hair and skin E is an external preparation for improving hair and skin using a preparation containing additives. Moreover, although the external preparation of this invention was created as a cream, it can be set as the form of external preparation compositions, such as ointment and lotion.
【The invention's effect】

本発明者の外用剤は1日1回皮膚への塗布により従来知られている皮膚の保湿効果、皮膚の日焼け、色黒、しみ、そばかす、老人性色素斑の美白効果、皮膚の皺とり作用のみでなく、更に本発明者の外用剤が含有するワクシニアウイルス接種家兎炎症皮膚抽出液の皮膚の掻痒を抑える効果により掻破が少なくなり、皮膚の表皮角質層の破壊が少なくなる。これは表皮角質層の改善の一因と考えられる。詳細は不明ですが、また本発明者の外用剤が表皮角質層等を改善する効果により、荒れた皮膚をつるつると滑らかな艶のある皮膚にする効果がある。更に皮膚の日焼け、色黒、しみ、そばかす、老人性色素斑などの黒い皮膚面を美白効果により白くし、白くなった皮膚面と、ビタミンEの末梢血管を拡張し血液循環を改善する効果等により、顔の特に頬の血色をよくする効果のある外用剤であり、この効果は血色の悪い人ほど顕著です。薄化粧の人なら頬紅がいらないぐらいです。人の交流で顔の血色を見て、顔色がいいね、元気そうね。又悪いと、どうかしたの、病気?と挨拶するほど、人の生活に大事なものです。この様に本発明者の外用剤は従来知られていた皮膚の保湿効果、日焼け、色黒、しみ、そばかす、老人性色素斑が薄くなるが消失する美白効果、皺が浅くなるか消失する効果、皮膚をつるつると滑らかな艶のある皮膚にする効果に加えて、更に本発明者の皮膚改善外用剤は皮膚面特に顔面の頬部の皮膚を血色のいい皮膚にする、従来知られていない新しい効果のある美肌外用剤である。今までこの様に1日1回1剤の塗布で保湿作用、日焼け、色黒、しみ、そばかす、老人性色素斑の美白効果、皮膚をつるつると滑らかな艶のある皮膚にする効果に血色のいい皮膚にする効果、皺とり作用のある美肌効果、更にしみ、そばかす、老人性色素斑、皺発生の予防効果を期待出来る外用薬はない。詳細は不明ですが、皮膚の表皮角質層、メラノサイト、真皮等に、この本発明者の外用剤が好影響を及ぼすものと考察する。又この本発明者の外用剤の全身に塗布することによる表皮角質層の健全化は、ウイルス、細菌、カビ、ダニ等の侵入を防ぎ、又アレルギー反応を起こりにくくし、さらに過度の紫外線、乾燥による皮膚の老化の防止になり、ひいては寿命の延長が期待されます。又紫外線の影響を早く除去する作用があるので、昼間はUVカットクリームを、夜間は本発明者の外用剤を使用すると、紫外線による皮膚への影響が少なくなり、色黒、しみ、そばかす、老人性色素斑、皺の発生も減少し、つるつるの滑らかな艶のある血色のいい美しい肌を長く維持でき、更に紫外線による皮膚癌の発生減少が期待されます。又紫外線は小児期から皮膚に損傷を与えているので、紫外線による色黒、しみ、そばかす、老人性色素斑、皺等皮膚変化の予防の為、色黒、しみ、そばかす、老人性色素斑、皺等皮膚の変化の発生前早期に、夜間は本発明者の外用剤の使用と昼間はUVカットクリームの使用による紫外線対策が望ましい。
(試験例1)
美肌効果については、男性4名、女性20名について検討した。各人使用方法の差により多少の差異はあるが、就寝前1日1回の塗布により、10日位使用すると、皮膚面がつるつると滑らかになり、約3ヶ月以上塗布すると、つるつると滑らかな艶のある皮膚になり、顔特に頬の血色もよくなり、また保湿効果もある。更に日焼け、しみ、そばかす、色黒、老人性色素斑の美白効果、皺が浅くなるか消失する皺とり効果を認め、肌が本発明者の外用剤の使用前に比べ一段と美しくなる美肌効果を認めた。
The external preparation of the present inventor is a skin moisturizing effect conventionally known by application to the skin once a day, tanning of the skin, dark skin, spots, freckles, whitening effect of senile pigment spots, skin removing action In addition, the effect of suppressing the skin itch of the rabbit skin-inoculated vaccinia virus inoculated vaccinia virus contained in the external preparation of the present inventor reduces the scratching and the destruction of the epidermal stratum corneum of the skin. This is thought to contribute to the improvement of the epidermal stratum corneum. Although details are unknown, the external preparation of the present inventor has the effect of improving the epidermal stratum corneum and the like, and has an effect of smoothening the rough skin to make it smooth and glossy. In addition, whitening of the skin, such as sunburn, dark skin, spots, freckles, and senile pigment spots, whitens the skin, whitening skin, and the expansion of peripheral blood vessels of vitamin E to improve blood circulation, etc. Therefore, it is a topical preparation that improves the color of the face, especially the cheeks, and this effect is more pronounced for people with poor blood. If you have a light makeup, you don't need blusher. Look at the color of the face through people's interaction, the face is nice and looks fine. If it was bad again, how did you get sick? The more you say, the more important it is to your life. As described above, the external preparation of the present inventor has conventionally known skin moisturizing effect, sunburn, dark black, blotch, freckles, whitening effect that makes senile pigment spots thin but disappears, effect that wrinkles become shallow or disappear Furthermore, in addition to the effect of making the skin smooth and smooth, the present inventor's skin improvement external preparation makes the skin surface, particularly the cheeks of the face, a ruddy skin, which has not been known so far It is an external preparation for skin that has a new effect. In this way, once a day, it is moisturizing, tanned, dark black, blots, freckles, whitening effect of senile pigment spots, and the effect of making the skin smooth and shiny skin There is no topical medicine that can be expected to have a good skin effect, a beautifying skin effect, a stain, freckles, senile pigment spots, and wrinkle-preventing effects. Although details are unknown, it is considered that the external preparation of the present inventor has a positive effect on the epidermal stratum corneum, melanocytes, dermis and the like of the skin. Also, the soundness of the epidermal stratum corneum by applying this inventor's external preparation to the whole body prevents the invasion of viruses, bacteria, molds, mites, etc., makes allergic reactions less likely, and excessive ultraviolet rays, dryness This will prevent the skin from aging, and it is expected to extend its lifespan. In addition, since it has the effect of removing the effects of ultraviolet rays quickly, using UV cut cream during the daytime and the inventor's external preparation at night will reduce the effects of ultraviolet rays on the skin. Occurrence of sexual pigment spots and wrinkles is also reduced, it is possible to maintain smooth, smooth, glossy, ruddy, beautiful skin for a long time, and to reduce the occurrence of skin cancer due to ultraviolet rays. In addition, since ultraviolet rays have damaged the skin since childhood, to prevent skin changes such as darkness, blotches, freckles, senile pigment spots, wrinkles, etc., ultraviolet rays, stains, freckles, freckles, senile pigment spots, It is desirable to take measures against ultraviolet rays by using the inventor's external preparation at night and in the daytime by using a UV cut cream at an early stage before the occurrence of skin changes such as wrinkles.
(Test Example 1)
The skin beautifying effect was examined for 4 men and 20 women. Although there are some differences depending on the usage method of each person, by applying once a day before going to bed, the skin surface becomes smooth when used for about 10 days, and when applied for about 3 months or more, it becomes smooth when smooth. It gives glossy skin, improves the color of the face, especially the cheeks, and has a moisturizing effect. In addition, the skin whitening effect of sunburn, spots, freckles, dark black, senile pigment spots, the wrinkle removal effect that makes the wrinkles shallower or disappears, and the skin beautifying effect that makes the skin more beautiful than before using the external preparation of the present inventor. Admitted.

【0018】
本発明者は発明者の外用剤が老化して弱った白髪を傷めないで、3〜4ヶ月毛髪に塗布することで、白髪のみを金髪に染毛する効果がある。従来の染毛剤は強酸、強アルカリで処理するので、毛皮質内の細胞膜複合体の損傷、溶出、内部蛋白質の溶出がおこり、毛髪の水分保持機能が低下し、環境の温度の変化を受けやすくなり、髪がパサついたり、ヘアースタイルのまとまりや、もちの悪さ、枝毛、切れ毛が起こる。更に毛皮質のF層がなくなり毛髪がギシギシした感触になる。本発明者の外用剤は強酸,強アルカリ剤を使用せず、毛髪に上記のような損傷をあたえず、むしろ艶がよくなり、生来の美しさを取り戻し、染毛時染毛剤による皮膚炎の発症はない。又1剤1日1回の毛髪、皮膚への塗布により、皮膚には保湿作用、日焼け、しみ、そばかす、老人性色素斑の美白作用、皺とり作用、つるつると滑らかな艶のある皮膚にする従来の効果に加えて、新しく見出した白髪を金髪に染毛するうえ、皮膚面特に顔の頬部の血色をよくする効果をもつ外用剤は今までない。
(試験例2)
白髪を金髪に染毛する試験は男性3名、女性6名で実施した。1日1回毛髪に塗布、約30日で薄く金髪に染まり始め、3〜4ヶ月程で全員金髪に染毛できた。染毛による毛髪の損傷はなく、むしろ艶が出て生来の美しさを取り戻した。本発明者の外用剤による皮膚炎の発生はない。
【実施例】
【0028】
本発明の外用剤には、クリーム基材として使用される親水軟膏と流動パラフインが使用されている。さらに、成分として、コエンザイムQ10、L−システイン、ビタミンA,C,E,抗アレルギー作用と掻痒に効果のあるワクシニアウイルス接種家兎炎症皮膚抽出液を加えた外用剤である。アトピー性皮膚炎の外用剤にはロラタジン、クレマスチンを追加配合すると効果が増す。保湿効果を増す為にはヒアルロン酸ナトリウムを追加配合する。使用した薬剤は、各薬剤の相互間が化学的に安定する為、又毛髪及び皮膚面での薬剤の安定吸収の為ビタミンCとワクシニアウイルス接種家兎炎症皮膚抽出液以外のコエンザイムQ10、Lシステイン、ビタミンA、ビタミンE、ロラタジン、クレマスチン、ヒアルロン酸ナトリウムは添加物入りの製剤を用いた。
製剤の添加物は
ロラタジンのクラリチン錠には乳糖、とうもろこし澱粉、ステアリンサンマグネシウム。
クレマスチンのラクレチンドライシロップにはDマントール、白糖。
ヒアルロン酸ナトリウムのヒアルトーワ注には塩化ナトリウム、リン酸水素ナトリウム、リン酸ニ水素ナトリウムです。
[0018]
The present inventor has the effect of dyeing only white hair into blond hair by applying it to the hair for 3 to 4 months without damaging the white hair weakened by the inventor's external preparation. Conventional hair dyes are treated with strong acids and strong alkalis, causing damage to the cell membrane complex in the fur, elution, and elution of internal proteins, reducing the moisture retention function of the hair and receiving changes in the temperature of the environment. It becomes easier, and the hair gets dry, the hair style is lumpy, the stickiness, split ends, and the hair ends. Furthermore, the fur layer of F disappears and the hair feels tingling. The external preparation of the present inventor does not use a strong acid or a strong alkali agent, does not give the hair damage as described above, rather becomes glossy, regains its natural beauty, and dermatitis due to a hair dye during hair dyeing. There is no onset of. In addition, once a day, once on a day's hair and skin, the skin is moisturized, tanned, stained, freckled, whitening of senile pigment spots, moisturizing, smooth and glossy skin. In addition to the conventional effects, there are no external preparations that have the effect of improving the color of the skin surface, particularly the cheeks of the face, in addition to dyeing newly discovered gray hair into blonde hair.
(Test Example 2)
The test for dyeing gray hair into blond hair was carried out by 3 men and 6 women. Applied to the one-time hair a day, beginning dyed in thin blonde in about 30 days, it could be dyed in all blonde in about three to four months. There was no damage to the hair due to the dyeing, but rather the luster appeared and the natural beauty was restored. There is no occurrence of dermatitis due to the external preparation of the present inventor.
【Example】
[0028]
In the external preparation of the present invention, hydrophilic ointment and fluid paraffin used as a cream base are used. Furthermore, it is an external preparation to which coenzyme Q10, L-cysteine, vitamins A, C, E, vaccinia virus-inoculated rabbit inflammatory skin extract effective for antiallergic action and pruritus are added as ingredients. The effect increases when loratadine and clemastine are added to the topical preparation for atopic dermatitis. To increase the moisturizing effect, sodium hyaluronate is added. The chemicals used were coenzyme Q10, L-cysteine other than vitamin C and vaccinia virus-inoculated rabbit inflammation skin extract for chemical stability between each drug and for stable absorption of the drug on the hair and skin surface. Vitamin A, vitamin E, loratadine, clemastine, and sodium hyaluronate used preparations containing additives.
Formulation additives
Lolatadine claritin tablets contain lactose, corn starch, and stearsanmagnesium.
Klemastine lacretin dry syrup contains D mannitol and sucrose.
Sodium hyaluronate hyaltowa injection is sodium chloride, sodium hydrogen phosphate, sodium dihydrogen phosphate.

(実施例3)
アトピー性皮膚炎の外用剤の効果を増すため、以下の組成で、常法により外用剤を製造した。
NEソフトカプセル(ニコチン酸トコフエロール200mg) 20錠(軟カプセルは取り除く)
チョコラA(パルミチン酸レチノール) 30ml
アデリール錠(コエンザイムQ10、ユビデカレノン)10mg 300錠(粉砕後)
ハイチオール散32%(Lシステイン) 15g
アスコルビン酸(日本薬局法) 20g
ナブトピン(ワクシニアウイルス接種家兎炎症皮膚抽出液)7.2単位 6ml
流動パラフイン(日本薬局法) 50ml
親水軟膏 (日本薬局法) 500g
クラリチン錠10mg(ロラタジン) 20錠(粉砕後)
(Example 3)
In order to increase the effect of the external preparation for atopic dermatitis, the external preparation was produced by the usual method with the following composition.
NE soft capsule (tocopherol nicotinate 200mg) 20 tablets (remove soft capsule)
Chocola A (retinol palmitate) 30ml
Adeliel Tablets (Coenzyme Q10, Ubidecarenone) 10mg 300 tablets (after grinding)
Hythiol powder 32% (L cysteine) 15g
Ascorbic acid (Japanese Pharmacy Law) 20g
Nabutopin (Vaccinia virus inoculated rabbit inflammation skin extract) 7.2 units 6ml
Flowing paraffin (Japanese Pharmacy Law) 50ml
Hydrophilic ointment (Japanese Pharmacy Law) 500g
Claritin tablets 10mg (loratadine) 20 tablets (after grinding)

(実施例4)
アトピー性皮膚炎の外用剤の効果を増すため、以下の組成で、常法により外用剤を製造した。
NEソフトカプセル(ニコチン酸トコフエロール200mg) 20錠(軟カプセルは取り除く)
チョコラA(パルミチン酸レチノール) 30ml
アデリール錠(コエンザイムQ10、ユビデカレノン)10mg 300錠(粉砕後)
ハイチオール散32%(Lシステイン) 15g
アスコルビン酸(日本薬局法) 20g
ナブトピン(ワクシニアウイルス接種家兎炎症皮膚抽出液)7.2単位 6ml
流動パラフイン(日本薬局法) 50ml
親水軟膏 (日本薬局法) 500g
ラクレチン ドライシロップ (フマル酸クレマスチン1.34mg)20g
Example 4
In order to increase the effect of the external preparation for atopic dermatitis, the external preparation was produced by the usual method with the following composition.
NE soft capsule (tocopherol nicotinate 200mg) 20 tablets (remove soft capsule)
Chocola A (retinol palmitate) 30ml
Adeliel Tablets (Coenzyme Q10, Ubidecarenone) 10mg 300 tablets (after grinding)
Hythiol powder 32% (L cysteine) 15g
Ascorbic acid (Japanese Pharmacy Law) 20g
Nabutopin (Vaccinia virus inoculated rabbit inflammation skin extract) 7.2 units 6ml
Flowing paraffin (Japanese Pharmacy Law) 50ml
Hydrophilic ointment (Japanese Pharmacy Law) 500g
Lacretin dry syrup (clemastine fumarate 1.34mg) 20g

本発明は毛髪を傷めず、皮膚炎も起こさないで白髪のみを金色に染色する効果がある毛髪改善外用剤に関する。The present invention relates to a hair improving external preparation which has an effect of dyeing only white hair in gold without damaging hair and causing dermatitis.

白髪はメラノサイトにおいてメラニンの生成が停止する髪の老化現象と思われる。従来は染毛により着色している。染毛により毛髪は損傷を受ける。染毛処理はパラフエニレンジアミンなどの低分子の色素前駆体を毛髪中で酸化重合し、発色させる方法が主である。この処理は過酸化水素を主剤とする酸化剤を用いた酸化反応である。この酸化反応を毛髪中で効率よく行うために、アルカリ剤を用いてPHが高い領域で処理が行われることから、酸化剤、アルカリ剤による損傷を受ける。これら薬液は毛小皮と毛小皮間の細胞膜復合体を通り、毛皮質内の細胞膜複合体を通じて毛髪内部に影響を及ぼし、細胞膜複合体そのものの溶出、毛髪内部の蛋白質の溶出が起こる。毛皮質には、毛髪の水分を保持する役割があるが、細胞膜複合体や内部の蛋白質の溶出によりその水分保持機能が損なわれる。そのため環境の温度変化の影響を受けやすくなり、パサつき、ヘアースタイルのまとまりや、もちの悪さ、枝毛や切れ毛の発生などの現象が起こる。更に毛髪表面を覆っている毛小皮の最表面はF層と呼ばれる脂質の層がある。F層に含まれる分岐脂肪酸により毛髪表面の滑らかな感触に関与する機能を持っている。この脂肪酸はアルカリ性溶液で処理すると加水分解され、結合している脂肪酸が遊離する、これで毛髪表面に存在していた疎水性の膜、F層がなくなり、毛髪がギシギシした感触になる。〔非特許文献1 最新の毛髪科学 松崎貴 p229〜236〕 White hair appears to be an aging phenomenon in which melanin production stops in melanocytes. Conventionally, it is colored by hair dyeing. Hair is damaged by hair dyeing. The hair dyeing treatment is mainly performed by oxidative polymerization of a low molecular weight dye precursor such as paraphenylenediamine in the hair to develop a color. This treatment is an oxidation reaction using an oxidizing agent mainly composed of hydrogen peroxide. In order to efficiently perform this oxidation reaction in the hair, the treatment is performed in a region where the pH is high using an alkali agent, and therefore, damage is caused by the oxidant and the alkali agent. These chemical solutions pass through the cell membrane union between the hair skin and the hair skin and affect the inside of the hair through the cell membrane complex in the fur, causing the cell membrane complex itself to elute and the protein inside the hair to elute. The fur has a role of retaining moisture in hair, but its moisture retention function is impaired by elution of cell membrane complexes and internal proteins. For this reason, it is easily affected by changes in the temperature of the environment, and there are phenomena such as dryness, grouping of hairstyles, poor texture, and generation of split ends and cut hairs. Furthermore, the outermost surface of the hair cuticle covering the hair surface has a lipid layer called F layer. The branched fatty acid contained in the F layer has a function related to the smooth feel of the hair surface. When this fatty acid is treated with an alkaline solution, it is hydrolyzed and the bound fatty acid is liberated, so that the hydrophobic film and F layer present on the hair surface disappear, and the hair feels tinged. [Non-Patent Document 1 Latest hair science Takashi Matsuzaki other p229~236]

本発明はコエンザイムQ10、システイン、ビタミンA,C、E,ワクシニアウイルス接種家兎炎症皮膚抽出液を含有する毛髪改善外用剤。 The present invention is an external preparation for improving hair containing coenzyme Q10, cysteine, vitamins A, C, E, vaccinia virus-inoculated rabbit inflammation skin extract .

本発明者は発明者の外用剤が老化して弱った白髪を傷めないで、3〜4ヶ月毛髪に塗布することで、白髪のみを金髪に染毛する効果がある。従来の染毛剤は強酸、強アルカリで処理するので、毛皮質内の細胞膜複合体の損傷、溶出、内部蛋白質の溶出がおこり、毛髪の水分保持機能が低下し、環境の温度の変化を受けやすくなり、髪がパサついたり、ヘアースタイルのまとまりや、もちの悪さ、枝毛、切れ毛が起こる。更に毛皮質のF層がなくなり毛髪がギシギシした感触になる。本発明者の外用剤は強酸,強アルカリ剤を使用せず、毛髪に上記のような損傷をあたえず、むしろ艶がよくなり、生来の美しさを取り戻し、染毛時染毛剤による皮膚炎の発症はない。又1剤1日1回の毛髪、皮膚への塗布により、皮膚には保湿作用、日焼け、しみ、そばかす、老人性色素斑の美白作用、皺とり作用、つるつると滑らかな艶のある皮膚にし、皮膚面特に顔の頬部の血色をよくする効果に加えて、新しく見出した白髪を金髪に染毛する効果をもつ外用剤は今までない。
(試験例1)
白髪を金髪に染毛する試験は男性3名、女性6名で実施した。1日1回毛髪に塗布、約30日で薄く金髪に染まり始め、3〜4ヶ月程で全員金髪に染毛できた。染毛による毛髪の損傷はなく、むしろ艶が出て生来の美しさを取り戻した。本発明者の外用剤による皮膚炎の発生はない。
The present inventor has an effect of dyeing only white hair into blond hair by applying it to the hair for 3 to 4 months without damaging the white hair weakened by the inventor's external preparation. Conventional hair dyes are treated with strong acids and strong alkalis, causing damage to the cell membrane complex in the fur, elution, and elution of internal proteins, reducing the moisture retention function of the hair and receiving changes in the temperature of the environment. It becomes easier, and the hair gets dry, the hair style is lumpy, the stickiness, split ends, and the hair ends. Furthermore, the fur layer of F disappears and the hair feels tingling. The external preparation of the present inventor does not use a strong acid or a strong alkali agent, does not give the hair damage as described above, rather becomes glossy, regains its natural beauty, and dermatitis due to a hair dye during hair dyeing. There is no onset of. Also, by applying to the hair and skin once a day, the skin is moisturized, tanned, stained, freckled, whitening of senile pigment spots, moisturizing, smooth and glossy skin. In addition to the effect of improving the color of the skin, especially the cheeks of the face, there has been no external preparation that has the effect of coloring newly found white hair into blond hair.
(Test Example 1)
The test for dyeing gray hair into blond hair was carried out by 3 men and 6 women. Once applied to hair once a day, it began to lightly fade into blonde hair in about 30 days. There was no damage to the hair due to the dyeing, but rather the luster appeared and the natural beauty was restored. There is no occurrence of dermatitis due to the external preparation of the present inventor.

【0028】
【実施例】
本発明の外用剤には、クリーム基材として使用される親水軟膏と流動パラフインが使用されている。さらに、成分として、コエンザイムQ10、L−システイン、ビタミンA,C,E,抗アレルギー作用と掻痒に効果のあるワクシニアウイルス接種家兎炎症皮膚抽出液を加えた外用剤である。
[0028]
【Example】
In the external preparation of the present invention, hydrophilic ointment and fluid paraffin used as a cream base are used. Furthermore, it is an external preparation to which coenzyme Q10, L-cysteine, vitamins A, C, E, vaccinia virus-inoculated rabbit inflammatory skin extract effective for antiallergic action and pruritus are added as ingredients.

Claims (11)

コエンザイムQ10、システイン、ビタミン類、ワクシニアウイルス接種家兎炎症皮膚抽出液等を含むことを特徴とする毛髪、皮膚改善外用剤。  An external preparation for improving hair and skin comprising coenzyme Q10, cysteine, vitamins, rabbit skin inoculated vaccinia virus inoculated inflammatory skin extract and the like. 請求項1のビタミン類がビタミンA、C、Eもしくはこれらの誘導体である請求項1に記載の毛髪、皮膚改善外用剤。  The external preparation for improving hair and skin according to claim 1, wherein the vitamins of claim 1 are vitamins A, C, E or derivatives thereof. 1剤1日1回皮膚への塗布により表皮角質層等を改善し、つるつると滑らかな艶のある皮膚にする効果、また皮膚の末梢血管を拡張し血液循環を改善すること等による肌の血色をよくする効果、更に保湿効果、美白効果、皺とり効果等の美肌効果を特徴とする請求項1または2記載の皮膚改善外用剤。  Applying once a day to the skin improves the epidermal stratum corneum, etc., and smoothes it to make the skin glossy, and the skin color by expanding peripheral blood vessels and improving blood circulation. The skin improvement external preparation according to claim 1 or 2, wherein the skin improvement external preparation further has a skin beautifying effect such as a moisturizing effect, a whitening effect, and a wrinkle removing effect. 毛髪に塗布することで白髪のみを金色に染毛するのを発見し、毛髪を傷めない、染毛者が皮膚炎を起こさないことを特徴とする請求項1ないし3記載の毛髪改善外用剤。  4. The external preparation for improving hair according to claim 1, wherein it is found that only white hair is dyed golden by applying it to the hair, the hair is not damaged, and the hair dye does not cause dermatitis. アトピー性皮膚炎の改善、又は治癒に使用するため、請求項1ないし4記載の外用剤に抗ヒスタミン剤、抗アレルギー剤を加えることを特徴とする皮膚改善外用剤。  A skin improvement external preparation characterized by adding an antihistamine or an antiallergic agent to the external preparation according to claim 1 to 4 for use in improving or healing atopic dermatitis. システイン類が、Lシステインもしくはこれらの誘導体等である請求項1ないし請求項5記載の毛髪、皮膚改善外用剤。  6. The external preparation for improving hair and skin according to claim 1, wherein the cysteine is L cysteine or a derivative thereof. ビタミンA類が、パルミチン酸レチノールもしくはこれらの誘導体等である請求項1ないし請求項6記載の毛髪、皮膚改善外用剤。  The external preparation for improving hair and skin according to claim 1, wherein the vitamin A is retinol palmitate or a derivative thereof. ビタミンC類が、アスコルビン酸もしくはこれらの誘導体等である請求項1ないし請求項7記載の毛髪、皮膚改善外用剤。  8. The external preparation for improving hair and skin according to claim 1, wherein the vitamin C is ascorbic acid or a derivative thereof. ビタミンE類が、トコフエロールもしくはこれらの誘導体等である請求項1ないし請求項8記載の毛髪、皮膚改善外用剤。  The hair and skin improvement external preparation according to claim 1 to 8, wherein the vitamin E is tocopherol or a derivative thereof. 請求項1ないし請求項9記載の毛髪、皮膚改善外用剤において、親水軟膏500重量部に対して、コエンザイムQ10(0.03〜1.2重量部)、Lシステイン(0.48〜2.4重量部)、ビタミンA(0.06〜0.36重量部)、ビタミンC(2.0〜8.0重量部)、ビタミンE(0.4〜1.6重量部)、抗アレルギー作用と掻痒に効果のあるワクシニアウイルス接種家兎炎症皮膚抽出液3.6〜14.4単位、3ml〜12ml、(0.6〜2.4重量部)、流動パラフイン(4.4〜13.2重量部)を有する外用剤を作成する。更に保湿効果を増す為にはヒアルロン酸ナトリウム(0.01〜0.1重量部)を加える2種類の外用剤を作成する。又アトピー性皮膚炎用外用剤にはヒアルロン酸ナトリウムを含まない本発明の外用剤に、抗アレルギー剤の抗アレルギー作用と掻痒に効果のあるロラタジン(0.01〜0.12重量部)、抗ヒスタミン剤の抗アレルギー作用と掻痒に効果のあるクレマスチン(0.001〜0.012重量部)を追加することを特徴とする毛髪、皮膚改善外用剤。  The hair and skin improvement external preparation according to any one of claims 1 to 9, wherein the coenzyme Q10 (0.03 to 1.2 parts by weight) and L cysteine (0.48 to 2.4) are added to 500 parts by weight of the hydrophilic ointment. Parts by weight), vitamin A (0.06-0.36 parts by weight), vitamin C (2.0-8.0 parts by weight), vitamin E (0.4-1.6 parts by weight), antiallergic action Vaccinia virus-inoculated rabbit inflammation skin extract effective for pruritus 3.6 to 14.4 units, 3 to 12 ml, (0.6 to 2.4 parts by weight), fluid paraffin (4.4 to 13.2% by weight) Part) is prepared. In order to further increase the moisturizing effect, two external preparations to which sodium hyaluronate (0.01 to 0.1 parts by weight) is added are prepared. Further, the topical preparation for atopic dermatitis does not contain sodium hyaluronate, and the loratadine (0.01 to 0.12 parts by weight) and antihistamine which are effective for the antiallergic action and pruritus of the antiallergic agent An external preparation for improving hair and skin, characterized by adding clemastine (0.001 to 0.012 parts by weight) effective for anti-allergic action and pruritus. 請求項1ないし請求項10記載の毛髪、皮膚改善外用剤において使用した薬剤は、各薬剤の相互間が化学的に安定する為、又毛髪及び皮膚面での薬剤の安定吸収の為ビタミンC以外のコエンザイムQ10、Lシステイン、ビタミンA、ビタミンE、ワクシニアウイルス接種家兎炎症皮膚抽出液、ロラタジン、クレマスチンは添加物入りの製剤を用いた毛髪、皮膚改善外用剤。  The medicines used in the hair and skin improvement external preparations according to claim 1 to claim 10 other than vitamin C for chemical stabilization between each medicine and for stable absorption of the medicine on the hair and skin. Coenzyme Q10, L cysteine, vitamin A, vitamin E, vaccinia virus inoculated rabbit inflammation skin extract, loratadine and clemastine are external preparations for hair and skin using preparations containing additives.
JP2005380876A 2005-12-07 2005-12-07 External agent for improving hair Expired - Fee Related JP3965521B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005380876A JP3965521B2 (en) 2005-12-07 2005-12-07 External agent for improving hair

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005380876A JP3965521B2 (en) 2005-12-07 2005-12-07 External agent for improving hair

Publications (2)

Publication Number Publication Date
JP2007153863A true JP2007153863A (en) 2007-06-21
JP3965521B2 JP3965521B2 (en) 2007-08-29

Family

ID=38238665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005380876A Expired - Fee Related JP3965521B2 (en) 2005-12-07 2005-12-07 External agent for improving hair

Country Status (1)

Country Link
JP (1) JP3965521B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008111384A1 (en) * 2007-03-13 2008-09-18 Haruzo Kobayashi Epithelium improving agent
JP2009067764A (en) * 2007-09-18 2009-04-02 Nippon Menaade Keshohin Kk Composition for hair
JP2018502907A (en) * 2014-12-22 2018-02-01 ロレアル 1- (3,4-Disubstituted) phenyl-2- (3,4-disubstituted) phenylethane compounds and uses thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4899224B2 (en) * 2010-05-11 2012-03-21 春三 小林 Arteriosclerosis improving agent

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008111384A1 (en) * 2007-03-13 2008-09-18 Haruzo Kobayashi Epithelium improving agent
EP2119446A1 (en) * 2007-03-13 2009-11-18 Haruzo Kobayashi Epithelium improving agent
EP2119446A4 (en) * 2007-03-13 2013-01-09 Haruzo Kobayashi Epithelium improving agent
US8529879B2 (en) 2007-03-13 2013-09-10 Haruzo Kobayashi Epithelium-improving agent
JP2009067764A (en) * 2007-09-18 2009-04-02 Nippon Menaade Keshohin Kk Composition for hair
JP2018502907A (en) * 2014-12-22 2018-02-01 ロレアル 1- (3,4-Disubstituted) phenyl-2- (3,4-disubstituted) phenylethane compounds and uses thereof
US10357440B2 (en) 2014-12-22 2019-07-23 L'oreal Composition comprising at least one 2-(3,4-disubstituted)phenyl-1-(3,4-disubstituted)phenyl-1-hydroxyethane for preventing and/or treating the signs of ageing of the skin

Also Published As

Publication number Publication date
JP3965521B2 (en) 2007-08-29

Similar Documents

Publication Publication Date Title
Vashi et al. Facial hyperpigmentation: causes and treatment
KR100928211B1 (en) Compositions for the treatment of sun damage and compositions for reducing acne lesions
EP2123252B1 (en) Method for increasing hair growth
JP4229842B2 (en) Cosmetic formulations containing L-arginine oligomers
US20110020252A1 (en) Method of long lasting human skin tanning
AU2016202140B2 (en) Compositions for skin exfoliation and use thereof
EP2244690B1 (en) Topical compositions for treating inflammatory disorders, diseases and conditions
KR20160067195A (en) Nicotinamide riboside compositions for topical use in treating skin conditions
US8911774B2 (en) Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use
WO2013187574A1 (en) Skin-whitening cosmetic composition
KR100673044B1 (en) The composition for external use by percutaneous administration
EP2763686A1 (en) Composition for the treatment of skin lesions
Wang et al. The application of skin care product in melasma treatment
JP2007153863A (en) Hair improving external preparation
US20110166222A1 (en) Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same
PL219738B1 (en) Composition for and method of therapeutically treating human skin using a novel retinoide
EP1752132A2 (en) Skin cosmetic compositions
KR20190137329A (en) Skin external application composition for anti-aging containing Phlox subulata extract
JPS61246130A (en) External agent for stimulation skin cell activity
EP4085894A1 (en) Composition for eye contour to prevent, reduce and/or eliminate skin imperfections
Mourelle et al. Cosmetic-Medical Treatments
Parikh et al. Skin 10 Cosmetics
AU2006202906A1 (en) Compositions for use with skin
Parikh et al. Skin Health and Healthy Aging: Skin Cosmetics
Afzal et al. Prospective randomized double‐blind comparative study of topical acetyl zingerone with tetrahexyldecyl ascorbate versus tetrahexyldecyl ascorbate alone on facial photoaging

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070207

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20070409

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070508

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070514

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100608

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130608

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130608

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130608

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130608

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130608

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees